<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet href="http://onlinelibrarystatic.wiley.com/xslt/wol-journal-rss.xsl"
            type="text/xsl"?><rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"><channel rdf:about="http://onlinelibrary.wiley.com/rss/journal/10.1111/(ISSN)1600-0897" xmlns="http://purl.org/rss/1.0/"><title>American Journal of Reproductive Immunology</title><description> Wiley Online Library : American Journal of Reproductive Immunology</description><link>http://dx.doi.org/10.1111%2F%28ISSN%291600-0897</link><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc</dc:publisher><dc:language xmlns:dc="http://purl.org/dc/elements/1.1/">en</dc:language><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/">© John Wiley &amp; Sons A/S</dc:rights><prism:issn xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">1046-7408</prism:issn><prism:eIssn xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">1600-0897</prism:eIssn><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-03-01T00:00:00-05:00</dc:date><prism:coverDisplayDate xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">March 2012</prism:coverDisplayDate><prism:volume xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">67</prism:volume><prism:number xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">3</prism:number><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">179</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">265</prism:endingPage><image rdf:resource="http://onlinelibrary.wiley.com/store/10.1111/aji.2012.67.issue-3/asset/cover.gif?v=1&amp;s=7ecd73d63347205ffad59129a1e49c706f441a46"/><items><rdf:Seq><rdf:li rdf:resource="http://dx.doi.org/10.1111%2Fj.1600-0897.2012.01106.x"/><rdf:li rdf:resource="http://dx.doi.org/10.1111%2Fj.1600-0897.2012.01105.x"/><rdf:li rdf:resource="http://dx.doi.org/10.1111%2Fj.1600-0897.2012.01104.x"/><rdf:li rdf:resource="http://dx.doi.org/10.1111%2Fj.1600-0897.2011.01099.x"/><rdf:li rdf:resource="http://dx.doi.org/10.1111%2Fj.1600-0897.2011.01103.x"/><rdf:li rdf:resource="http://dx.doi.org/10.1111%2Fj.1600-0897.2011.01102.x"/><rdf:li rdf:resource="http://dx.doi.org/10.1111%2Fj.1600-0897.2011.01101.x"/><rdf:li rdf:resource="http://dx.doi.org/10.1111%2Fj.1600-0897.2011.01097.x"/><rdf:li rdf:resource="http://dx.doi.org/10.1111%2Fj.1600-0897.2011.01100.x"/><rdf:li rdf:resource="http://dx.doi.org/10.1111%2Fj.1600-0897.2011.01098.x"/><rdf:li rdf:resource="http://dx.doi.org/10.1111%2Fj.1600-0897.2011.01096.x"/><rdf:li rdf:resource="http://dx.doi.org/10.1111%2Fj.1600-0897.2011.01094.x"/><rdf:li rdf:resource="http://dx.doi.org/10.1111%2Fj.1600-0897.2011.01089.x"/><rdf:li rdf:resource="http://dx.doi.org/10.1111%2Fj.1600-0897.2011.01086.x"/><rdf:li rdf:resource="http://dx.doi.org/10.1111%2Fj.1600-0897.2011.01087.x"/><rdf:li rdf:resource="http://dx.doi.org/10.1111%2Fj.1600-0897.2011.01081.x"/><rdf:li rdf:resource="http://dx.doi.org/10.1111%2Fj.1600-0897.2011.01071.x"/><rdf:li rdf:resource="http://dx.doi.org/10.1111%2Fj.1600-0897.2011.01088.x"/><rdf:li rdf:resource="http://dx.doi.org/10.1111%2Fj.1600-0897.2011.01093.x"/><rdf:li rdf:resource="http://dx.doi.org/10.1111%2Fj.1600-0897.2011.01079.x"/><rdf:li rdf:resource="http://dx.doi.org/10.1111%2Fj.1600-0897.2011.01080.x"/><rdf:li rdf:resource="http://dx.doi.org/10.1111%2Fj.1600-0897.2011.01085.x"/><rdf:li rdf:resource="http://dx.doi.org/10.1111%2Fj.1600-0897.2011.01082.x"/><rdf:li rdf:resource="http://dx.doi.org/10.1111%2Fj.1600-0897.2011.01084.x"/><rdf:li rdf:resource="http://dx.doi.org/10.1111%2Fj.1600-0897.2011.01090.x"/><rdf:li rdf:resource="http://dx.doi.org/10.1111%2Fj.1600-0897.2011.01092.x"/><rdf:li rdf:resource="http://dx.doi.org/10.1111%2Fj.1600-0897.2011.01068.x"/></rdf:Seq></items></channel><item rdf:about="http://dx.doi.org/10.1111%2Fj.1600-0897.2012.01106.x" xmlns="http://purl.org/rss/1.0/"><title>Explants of Intact Endometrium to Model Bovine Innate Immunity and Inflammation Ex Vivo</title><link>http://dx.doi.org/10.1111%2Fj.1600-0897.2012.01106.x</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Explants of Intact Endometrium to Model Bovine Innate Immunity and Inflammation Ex Vivo</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Álan Maia Borges</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Gareth David Healey</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Iain Martin Sheldon</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-02-13T03:32:19.96501-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/j.1600-0897.2012.01106.x</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/j.1600-0897.2012.01106.x</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1111%2Fj.1600-0897.2012.01106.x</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Original Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[<div class="section" id="aji1106-sec-0001" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Problem</h3><div class="para"><p>Bacterial infections commonly cause bovine endometritis and infertility via innate immune pathways. However, mechanistic studies using isolated cells or chopped tissue may be compromised by the disruption of endometrial architecture and release of damage-associated molecular patterns. So, this study aimed to establish an <em>ex vivo</em> model of intact bovine endometrium to study innate immunity and inflammation.</p></div></div><div class="section" id="aji1106-sec-0002" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Method of study</h3><div class="para"><p>Intact bovine endometrium explants were collected using a sterile 8-mm punch biopsy and cultured <em>ex vivo</em> with bacteria or pathogen-associated molecules. Interleukin accumulation was measured, and tissue viability was assessed by microscopy, TdT-mediated biotin–dUTP nick-end labelling and lactate dehydrogenase assay.</p></div></div><div class="section" id="aji1106-sec-0003" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Results</h3><div class="para"><p>Intact endometrium explants accumulated IL-6, IL-1β and IL-8 in response to Gram-negative or Gram-positive bacteria, and their purified pathogen-associated molecules; inflammatory responses were dependent on the stage of oestrous cycle. Explants of intact endometrium maintained viability and tissue architecture, and had lower basal accumulation of interleukins compared with explants using chopped endometrium.</p></div></div><div class="section" id="aji1106-sec-0004" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Conclusion</h3><div class="para"><p>This study established a tractable <em>ex vivo</em> model of intact endometrium to explore the mechanisms of immunity and inflammation in the bovine endometrium.</p></div></div>]]></content:encoded><description>ProblemBacterial infections commonly cause bovine endometritis and infertility via innate immune pathways. However, mechanistic studies using isolated cells or chopped tissue may be compromised by the disruption of endometrial architecture and release of damage-associated molecular patterns. So, this study aimed to establish an ex vivo model of intact bovine endometrium to study innate immunity and inflammation.Method of studyIntact bovine endometrium explants were collected using a sterile 8-mm punch biopsy and cultured ex vivo with bacteria or pathogen-associated molecules. Interleukin accumulation was measured, and tissue viability was assessed by microscopy, TdT-mediated biotin–dUTP nick-end labelling and lactate dehydrogenase assay.ResultsIntact endometrium explants accumulated IL-6, IL-1β and IL-8 in response to Gram-negative or Gram-positive bacteria, and their purified pathogen-associated molecules; inflammatory responses were dependent on the stage of oestrous cycle. Explants of intact endometrium maintained viability and tissue architecture, and had lower basal accumulation of interleukins compared with explants using chopped endometrium.ConclusionThis study established a tractable ex vivo model of intact endometrium to explore the mechanisms of immunity and inflammation in the bovine endometrium.</description></item><item rdf:about="http://dx.doi.org/10.1111%2Fj.1600-0897.2012.01105.x" xmlns="http://purl.org/rss/1.0/"><title>Detailed Analysis of Peripheral Blood Natural Killer Cells in Women with Repeated IVF Failure</title><link>http://dx.doi.org/10.1111%2Fj.1600-0897.2012.01105.x</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Detailed Analysis of Peripheral Blood Natural Killer Cells in Women with Repeated IVF Failure</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Gavin Sacks</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Yang Yang</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Elizabeth Gowen</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Susan Smith</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Louise Fay</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Michael Chapman</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-02-01T21:53:33.56514-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/j.1600-0897.2012.01105.x</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/j.1600-0897.2012.01105.x</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1111%2Fj.1600-0897.2012.01105.x</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Original Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[<div class="section" id="aji1105-sec-0001" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Problem</h3><div class="para"><p>To analyse the peripheral blood NK cells in women with repeated IVF failure (RIF) and a fertile control group to determine which parameters best differentiate the two populations.</p></div></div><div class="section" id="aji1105-sec-0002" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Methods</h3><div class="para"><p>Peripheral blood from the luteal phase of 171 women with RIF and 33 fertile controls was analysed by four-colour flow cytometry for NK cell concentration, subset differentiation and the activation marker CD69.</p></div></div><div class="section" id="aji1105-sec-0003" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Results</h3><div class="para"><p>Women with RIF had significantly increased NK cell numbers as determined by concentration (<em>P</em> &lt; 0.05) and percentage of lymphocytes (<em>P</em> &lt; 0.001), increased concentration of the CD56<sup>dim</sup> subtype (<em>P</em> &lt; 0.05), and increased concentration of activated CD56<sup>dim</sup>CD69<sup>+</sup> cells (<em>P</em> = 0.0001). There was no correlation between any NK cell parameters with the length of infertility or number of embryo transfer cycles.</p></div></div><div class="section" id="aji1105-sec-0004" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Conclusions</h3><div class="para"><p>Peripheral blood NK cell activity is significantly higher in women with RIF than in fertile controls. Future trials of immune therapy in women undergoing IVF should target those with high NK activity.</p></div></div>]]></content:encoded><description>ProblemTo analyse the peripheral blood NK cells in women with repeated IVF failure (RIF) and a fertile control group to determine which parameters best differentiate the two populations.MethodsPeripheral blood from the luteal phase of 171 women with RIF and 33 fertile controls was analysed by four-colour flow cytometry for NK cell concentration, subset differentiation and the activation marker CD69.ResultsWomen with RIF had significantly increased NK cell numbers as determined by concentration (P &lt; 0.05) and percentage of lymphocytes (P &lt; 0.001), increased concentration of the CD56dim subtype (P &lt; 0.05), and increased concentration of activated CD56dimCD69+ cells (P = 0.0001). There was no correlation between any NK cell parameters with the length of infertility or number of embryo transfer cycles.ConclusionsPeripheral blood NK cell activity is significantly higher in women with RIF than in fertile controls. Future trials of immune therapy in women undergoing IVF should target those with high NK activity.</description></item><item rdf:about="http://dx.doi.org/10.1111%2Fj.1600-0897.2012.01104.x" xmlns="http://purl.org/rss/1.0/"><title>Placental Villous Expression of TNFα and IL-10 and Effect of Oxygen Tension in Euploid Early Pregnancy Failure</title><link>http://dx.doi.org/10.1111%2Fj.1600-0897.2012.01104.x</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Placental Villous Expression of TNFα and IL-10 and Effect of Oxygen Tension in Euploid Early Pregnancy Failure</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Jean Calleja-Agius</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Eric Jauniaux</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Shanthi Muttukrishna</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-01-16T04:29:26.792909-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/j.1600-0897.2012.01104.x</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/j.1600-0897.2012.01104.x</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1111%2Fj.1600-0897.2012.01104.x</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Original Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[<div class="section" id="aji1104-sec-0001" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Problem</h3><div class="para"><p>The objective was to investigate placental inflammation in chromosomally normal miscarriages <em>in vivo</em> and <em>in vitro</em>.</p></div></div><div class="section" id="aji1104-sec-0002" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Method of study</h3><div class="para"><p>Chorionic villous tissue was collected from missed miscarriages and normal gestation-matched controls and cultured at 6 and 20% O<sub>2</sub> concentrations. Tissue was karyotyped. Flowcytometric bead arrays and real-time PCR were carried out for protein and gene expression studies.</p></div></div><div class="section" id="aji1104-sec-0003" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Results</h3><div class="para"><p>The levels of TNFα and IL-10 were significantly (<em>P</em> &lt; 0.005 and <em>P</em> &lt; 0.05) higher, and the levels of TNF-R1 and TNF-R2 were significantly (<em>P</em> &lt; 0.01 and <em>P</em> &lt; 0.05) lower in culture conditioned medium of villous explants of miscarriages compared to control group. Villous tissue homogenates from miscarriages contained significantly (<em>P</em> &lt; 0.005) lower levels of TNF-R1. There was a significant O<sub>2</sub>-dependent increase in the secretion of IL-10 (<em>P</em> &lt; 0.01) and decrease in TNFα/IL-10 ratio (<em>P</em> &lt; 0.005) in the culture medium in both groups.</p></div></div><div class="section" id="aji1104-sec-0004" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Conclusion</h3><div class="para"><p>Increased levels of TNFα and decreased levels of receptors in miscarriage villous tissue confirm an excessive placental inflammation in miscarriage patients.</p></div></div>]]></content:encoded><description>ProblemThe objective was to investigate placental inflammation in chromosomally normal miscarriages in vivo and in vitro.Method of studyChorionic villous tissue was collected from missed miscarriages and normal gestation-matched controls and cultured at 6 and 20% O2 concentrations. Tissue was karyotyped. Flowcytometric bead arrays and real-time PCR were carried out for protein and gene expression studies.ResultsThe levels of TNFα and IL-10 were significantly (P &lt; 0.005 and P &lt; 0.05) higher, and the levels of TNF-R1 and TNF-R2 were significantly (P &lt; 0.01 and P &lt; 0.05) lower in culture conditioned medium of villous explants of miscarriages compared to control group. Villous tissue homogenates from miscarriages contained significantly (P &lt; 0.005) lower levels of TNF-R1. There was a significant O2-dependent increase in the secretion of IL-10 (P &lt; 0.01) and decrease in TNFα/IL-10 ratio (P &lt; 0.005) in the culture medium in both groups.ConclusionIncreased levels of TNFα and decreased levels of receptors in miscarriage villous tissue confirm an excessive placental inflammation in miscarriage patients.</description></item><item rdf:about="http://dx.doi.org/10.1111%2Fj.1600-0897.2011.01099.x" xmlns="http://purl.org/rss/1.0/"><title>Induction of Cyclooxygenase (COX)-2 in Human Vaginal Epithelial Cells in Response to TLR ligands and TNF-α</title><link>http://dx.doi.org/10.1111%2Fj.1600-0897.2011.01099.x</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Induction of Cyclooxygenase (COX)-2 in Human Vaginal Epithelial Cells in Response to TLR ligands and TNF-α</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Theresa Joseph</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Irina A. Zalenskaya</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Nazita Yousefieh</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Suzanne D. Schriver</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Lyn C. Cote</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Neelima Chandra</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Gustavo F. Doncel</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-01-11T21:20:26.942679-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/j.1600-0897.2011.01099.x</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/j.1600-0897.2011.01099.x</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1111%2Fj.1600-0897.2011.01099.x</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Original Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[<div class="section" id="aji1099-sec-0001" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Problem</h3><div class="para"><p>Mucosal inflammation caused by infections of the female lower genital tract is considered to be an important cofactor for HIV transmission. We hypothesize that COX-2, a key inflammation-related enzyme, is involved in these responses and is upregulated by microbial ligands and pro-inflammatory cytokines.</p></div></div><div class="section" id="aji1099-sec-0002" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Method of study</h3><div class="para"><p>Human vaginal epithelial cells (VK-2/E6E7) and ectocervical biopsy tissues were stimulated with TLR ligands and the cytokine TNF-α, used as surrogates of vaginal infections, and assessed for COX-2 expression and activity by microarray, real-time RT-PCR, immunoblotting, immunohistochemistry, and ELISA.</p></div></div><div class="section" id="aji1099-sec-0003" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Results</h3><div class="para"><p>TLR agonists and TNF-α induce transcriptional and translational expression of COX-2 in vaginal cells. TLR ligands, MALP2, Pam3CSK4, LTA, and imiquimod induced high epithelial COX-2 expression, while zymosan and poly dI:dC induced very low enzyme expression. Induced mRNA and protein expression correlated with increased COX-2 activity, which led to increased levels of PGE<sub>2</sub> in the cell culture supernatant. These cell-based findings were confirmed in primary cervicovaginal tissue explants.</p></div></div><div class="section" id="aji1099-sec-0004" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Conclusion</h3><div class="para"><p>Induction of COX-2 expression and activity and the consequent increased levels of prostaglandins are common inflammatory pathways in human cervicovaginal epithelial cells and tissues in response to diverse TLR ligands and pro-inflammatory cytokines. These findings are relevant to the understanding of genital mucosal inflammation, its potential treatment, and its possible relationship with increased tissue susceptibility to HIV-1 infection.</p></div></div>]]></content:encoded><description>ProblemMucosal inflammation caused by infections of the female lower genital tract is considered to be an important cofactor for HIV transmission. We hypothesize that COX-2, a key inflammation-related enzyme, is involved in these responses and is upregulated by microbial ligands and pro-inflammatory cytokines.Method of studyHuman vaginal epithelial cells (VK-2/E6E7) and ectocervical biopsy tissues were stimulated with TLR ligands and the cytokine TNF-α, used as surrogates of vaginal infections, and assessed for COX-2 expression and activity by microarray, real-time RT-PCR, immunoblotting, immunohistochemistry, and ELISA.ResultsTLR agonists and TNF-α induce transcriptional and translational expression of COX-2 in vaginal cells. TLR ligands, MALP2, Pam3CSK4, LTA, and imiquimod induced high epithelial COX-2 expression, while zymosan and poly dI:dC induced very low enzyme expression. Induced mRNA and protein expression correlated with increased COX-2 activity, which led to increased levels of PGE2 in the cell culture supernatant. These cell-based findings were confirmed in primary cervicovaginal tissue explants.ConclusionInduction of COX-2 expression and activity and the consequent increased levels of prostaglandins are common inflammatory pathways in human cervicovaginal epithelial cells and tissues in response to diverse TLR ligands and pro-inflammatory cytokines. These findings are relevant to the understanding of genital mucosal inflammation, its potential treatment, and its possible relationship with increased tissue susceptibility to HIV-1 infection.</description></item><item rdf:about="http://dx.doi.org/10.1111%2Fj.1600-0897.2011.01103.x" xmlns="http://purl.org/rss/1.0/"><title>Toll-Like Receptor Expression and Function in the COV434 Granulosa Cell Line</title><link>http://dx.doi.org/10.1111%2Fj.1600-0897.2011.01103.x</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Toll-Like Receptor Expression and Function in the COV434 Granulosa Cell Line</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Jennifer Claire Price</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">James Cronin</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Iain Martin Sheldon</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-01-11T21:11:13.486522-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/j.1600-0897.2011.01103.x</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/j.1600-0897.2011.01103.x</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1111%2Fj.1600-0897.2011.01103.x</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Original Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[<div class="section" id="aji1103-sec-0001" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Problem</h3><div class="para"><p>Bacterial infections perturb ovarian follicle function, despite the lack of immune cells such as macrophages within healthy ovarian follicles. This study examined whether the granulosa cells that line ovarian follicles could, like macrophages, use Toll-like receptors (TLRs) to detect pathogen-associated molecular patterns (PAMPs) and initiate inflammation.</p></div></div><div class="section" id="aji1103-sec-0002" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Method of study</h3><div class="para"><p>The COV434 human granulosa and THP-1 macrophage cell lines were used to determine the expression of TLRs and measure the production of cytokines, chemokines and estradiol in response to the PAMPs lipopolysaccharide, peptidoglycan, lipoteichoic acid and flagellin from bacteria.</p></div></div><div class="section" id="aji1103-sec-0003" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Results</h3><div class="para"><p>The THP-1 and granulosa cells expressed mRNA for <i>TLR1-10</i> and <i>TLR4-10</i>, respectively. The supernatants of THP-1 cells accumulated IL-1β, IL-6, IL-8 and CCL5 in response to PAMPs. Treatment of granulosa cells with PAMPs increased expression of <i>IL1B</i> mRNA after 3 hr, but did not change the accumulation of IL-1β, IL-6, IL-8, CCL5 or estradiol. Granulosa cells produced IL-8 constitutively, and this was reduced using chemical inhibitors for p38 and JNK mitogen-activated protein kinases.</p></div></div><div class="section" id="aji1103-sec-0004" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Conclusion</h3><div class="para"><p>The COV434 human granulosa cell line expresses TLRs and constitutively secretes IL-8 but only mounts an inflammatory response to PAMPs at the transcriptional level.</p></div></div>]]></content:encoded><description>ProblemBacterial infections perturb ovarian follicle function, despite the lack of immune cells such as macrophages within healthy ovarian follicles. This study examined whether the granulosa cells that line ovarian follicles could, like macrophages, use Toll-like receptors (TLRs) to detect pathogen-associated molecular patterns (PAMPs) and initiate inflammation.Method of studyThe COV434 human granulosa and THP-1 macrophage cell lines were used to determine the expression of TLRs and measure the production of cytokines, chemokines and estradiol in response to the PAMPs lipopolysaccharide, peptidoglycan, lipoteichoic acid and flagellin from bacteria.ResultsThe THP-1 and granulosa cells expressed mRNA for TLR1-10 and TLR4-10, respectively. The supernatants of THP-1 cells accumulated IL-1β, IL-6, IL-8 and CCL5 in response to PAMPs. Treatment of granulosa cells with PAMPs increased expression of IL1B mRNA after 3 hr, but did not change the accumulation of IL-1β, IL-6, IL-8, CCL5 or estradiol. Granulosa cells produced IL-8 constitutively, and this was reduced using chemical inhibitors for p38 and JNK mitogen-activated protein kinases.ConclusionThe COV434 human granulosa cell line expresses TLRs and constitutively secretes IL-8 but only mounts an inflammatory response to PAMPs at the transcriptional level.</description></item><item rdf:about="http://dx.doi.org/10.1111%2Fj.1600-0897.2011.01102.x" xmlns="http://purl.org/rss/1.0/"><title>Serum sTREM-1 (Soluble Triggering Receptor Expressed on Myeloid Cells-1) Associates Negatively with Embryo Quality in Infertility Patients</title><link>http://dx.doi.org/10.1111%2Fj.1600-0897.2011.01102.x</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Serum sTREM-1 (Soluble Triggering Receptor Expressed on Myeloid Cells-1) Associates Negatively with Embryo Quality in Infertility Patients</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Kadri Haller-Kikkatalo</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Aili Sarapik</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Gilbert C. Faure</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Marie-Christine Béné</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Frédéric Massin</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Andres Salumets</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Raivo Uibo</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-01-09T21:55:40.206566-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/j.1600-0897.2011.01102.x</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/j.1600-0897.2011.01102.x</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1111%2Fj.1600-0897.2011.01102.x</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Original Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[<div class="section" id="aji1102-sec-0001" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Problem</h3><div class="para"><p>Soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) is a useful biomarker of infection and inflammation.</p></div></div><div class="section" id="aji1102-sec-0002" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Method of study</h3><div class="para"><p>We studied serum and follicular fluid sTREM-1 in infertile patients (<em>N</em> = 110) utilizing enzyme-linked immunosorbent assay.</p></div></div><div class="section" id="aji1102-sec-0003" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Results</h3><div class="para"><p>Serum and follicular sTREM-1 were in good correlation (Pearson's correlation 0.56, <em>P</em> &lt; 0.0001) with higher values in follicular fluid (140.4 ± 34.4 and 115.6 ± 35.1 pg/mL,<em> t</em>-test, <em>P</em> &lt; 0.0001). Endometriosis associated with lower follicular and serum sTREM-1 compared with male factor infertility patients (age-adjusted <em>r</em> = −25.7 pg/mL,<em>P</em> = 0.018; <em>r</em> = −22.1 pg/mL,<em>P</em> = 0.030). No associations between follicular or serum sTREM-1 and clinical parameters were found, except higher serum sTREM-1 associated with lower embryo quality in all patients (adjusted <em>r</em> = −0.3%, <em>P</em> = 0.033), with a cutoff value between 111.5 and 113.3 pg/mL (OR = 0.38, <em>P</em> = 0.048; OR = 0.34, <em>P</em> = 0.028) predicting that more than 39% of embryos would be with good quality.</p></div></div><div class="section" id="aji1102-sec-0004" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Conclusion</h3><div class="para"><p>Serum sTREM-1 could represent a prognostic marker for female fecundity, probably indicating impaired inflammatory reaction of immune system.</p></div></div>]]></content:encoded><description>ProblemSoluble triggering receptor expressed on myeloid cells-1 (sTREM-1) is a useful biomarker of infection and inflammation.Method of studyWe studied serum and follicular fluid sTREM-1 in infertile patients (N = 110) utilizing enzyme-linked immunosorbent assay.ResultsSerum and follicular sTREM-1 were in good correlation (Pearson's correlation 0.56, P &lt; 0.0001) with higher values in follicular fluid (140.4 ± 34.4 and 115.6 ± 35.1 pg/mL, t-test, P &lt; 0.0001). Endometriosis associated with lower follicular and serum sTREM-1 compared with male factor infertility patients (age-adjusted r = −25.7 pg/mL,P = 0.018; r = −22.1 pg/mL,P = 0.030). No associations between follicular or serum sTREM-1 and clinical parameters were found, except higher serum sTREM-1 associated with lower embryo quality in all patients (adjusted r = −0.3%, P = 0.033), with a cutoff value between 111.5 and 113.3 pg/mL (OR = 0.38, P = 0.048; OR = 0.34, P = 0.028) predicting that more than 39% of embryos would be with good quality.ConclusionSerum sTREM-1 could represent a prognostic marker for female fecundity, probably indicating impaired inflammatory reaction of immune system.</description></item><item rdf:about="http://dx.doi.org/10.1111%2Fj.1600-0897.2011.01101.x" xmlns="http://purl.org/rss/1.0/"><title>Lipoxin A4 Inhibits the Development of Endometriosis in Mice: The Role of Anti-Inflammation and Anti-Angiogenesis</title><link>http://dx.doi.org/10.1111%2Fj.1600-0897.2011.01101.x</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Lipoxin A4 Inhibits the Development of Endometriosis in Mice: The Role of Anti-Inflammation and Anti-Angiogenesis</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Zhangye Xu</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Feng Zhao</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Feng Lin</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Jinxia Chen</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Yingping Huang</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-01-09T21:55:27.444725-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/j.1600-0897.2011.01101.x</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/j.1600-0897.2011.01101.x</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1111%2Fj.1600-0897.2011.01101.x</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Original Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[<div class="section" id="aji1101-sec-0001" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Problem</h3><div class="para"><p>To evaluate the effects of the anti-inflammatory and anti-angiogenic roles of LXA4 on endometriosis in mice.</p></div></div><div class="section" id="aji1101-sec-0002" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Method of study</h3><div class="para"><p>Endometriosis was induced in 40 mice and separated into two groups. LXA4 group was administered by LXA4 for 3 weeks. The endometriotic lesions were counted, measured, and identified by pathology. The presence of a panel of pro-inflammatory factors was assessed by real-time RT-PCR, and enzyme-linked immunoassay, the mRNA, protein levels of matrix metalloproteinase (MMPs), and vascular endothelial growth factor (VEGF) were determined by real-time RT-PCR and immunohistochemistry; the activity of MMPs was evaluated by gelatin zymography.</p></div></div><div class="section" id="aji1101-sec-0003" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Results</h3><div class="para"><p>Treatment with LXA4 significantly inhibited endometriotic lesion development (13.58 ± 4.01 mm<sup>2</sup> in LXA4 group and 23.20 ± 7.49 mm<sup>2</sup>, <em>P </em>= 0.0002), downregulated pro-inflammatory factors, suppressed the activity of MMP9, and reduced the VEGF levels associated with endometriosis in mice.</p></div></div><div class="section" id="aji1101-sec-0004" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Conclusion</h3><div class="para"><p>LXA4 may inhibit the progression of endometriosis possibly by anti-inflammation and anti-angiogenesis.</p></div></div>]]></content:encoded><description>ProblemTo evaluate the effects of the anti-inflammatory and anti-angiogenic roles of LXA4 on endometriosis in mice.Method of studyEndometriosis was induced in 40 mice and separated into two groups. LXA4 group was administered by LXA4 for 3 weeks. The endometriotic lesions were counted, measured, and identified by pathology. The presence of a panel of pro-inflammatory factors was assessed by real-time RT-PCR, and enzyme-linked immunoassay, the mRNA, protein levels of matrix metalloproteinase (MMPs), and vascular endothelial growth factor (VEGF) were determined by real-time RT-PCR and immunohistochemistry; the activity of MMPs was evaluated by gelatin zymography.ResultsTreatment with LXA4 significantly inhibited endometriotic lesion development (13.58 ± 4.01 mm2 in LXA4 group and 23.20 ± 7.49 mm2, P = 0.0002), downregulated pro-inflammatory factors, suppressed the activity of MMP9, and reduced the VEGF levels associated with endometriosis in mice.ConclusionLXA4 may inhibit the progression of endometriosis possibly by anti-inflammation and anti-angiogenesis.</description></item><item rdf:about="http://dx.doi.org/10.1111%2Fj.1600-0897.2011.01097.x" xmlns="http://purl.org/rss/1.0/"><title>Effects of Acupuncture on LIF and IL-12 in Rats of Implantation Failure</title><link>http://dx.doi.org/10.1111%2Fj.1600-0897.2011.01097.x</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Effects of Acupuncture on LIF and IL-12 in Rats of Implantation Failure</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Juan Gui</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Fan Xiong</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Jing Li</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Guangying Huang</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-01-09T21:24:34.928746-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/j.1600-0897.2011.01097.x</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/j.1600-0897.2011.01097.x</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1111%2Fj.1600-0897.2011.01097.x</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Original Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[<div class="section" id="aji1097-sec-0001" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Problem</h3><div class="para"><p>Acupuncture has a positive effect on implantation obstacle, but the mechanism is still not clear, so the aim of the experiment is to explore the possible role that acupuncture plays in implantation.</p></div></div><div class="section" id="aji1097-sec-0002" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Method of study</h3><div class="para"><p>Early pregnant rats were randomized into normal group (N), group treated with mifepristone (M), acupuncture treatment group (A), and progestin treatment group (P). The model of blastocyst implantation obstacle in groups M, A, and P was established with mifepristone. Bilateral ‘Housanli’ and ‘Sanyinjiao’ were needled in group A. The expression of interleukin (IL)-12, leukemia inhibitory factor (LIF), LIFR protein, and mRNA in endometrium were detected.</p></div></div><div class="section" id="aji1097-sec-0003" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Results</h3><div class="para"><p>Positivity of the protein expression of IL-12, LIF, and LIFR in the endometrium was significantly higher in groups N, A, and P; positivity of the mRNA of IL-12 and LIF in the endometrium was significantly higher in groups N, A, and P.</p></div></div><div class="section" id="aji1097-sec-0004" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Conclusion</h3><div class="para"><p>Acupuncture could improve the poor receptive state of endometrium by promoting LIF and IL-12 secretion to improve blastocyst implantation.</p></div></div>]]></content:encoded><description>ProblemAcupuncture has a positive effect on implantation obstacle, but the mechanism is still not clear, so the aim of the experiment is to explore the possible role that acupuncture plays in implantation.Method of studyEarly pregnant rats were randomized into normal group (N), group treated with mifepristone (M), acupuncture treatment group (A), and progestin treatment group (P). The model of blastocyst implantation obstacle in groups M, A, and P was established with mifepristone. Bilateral ‘Housanli’ and ‘Sanyinjiao’ were needled in group A. The expression of interleukin (IL)-12, leukemia inhibitory factor (LIF), LIFR protein, and mRNA in endometrium were detected.ResultsPositivity of the protein expression of IL-12, LIF, and LIFR in the endometrium was significantly higher in groups N, A, and P; positivity of the mRNA of IL-12 and LIF in the endometrium was significantly higher in groups N, A, and P.ConclusionAcupuncture could improve the poor receptive state of endometrium by promoting LIF and IL-12 secretion to improve blastocyst implantation.</description></item><item rdf:about="http://dx.doi.org/10.1111%2Fj.1600-0897.2011.01100.x" xmlns="http://purl.org/rss/1.0/"><title>Rapid and Transient Upregulation of CCL11 (Eotaxin-1) in Mouse Ovary During Terminal Stages of Follicular Development</title><link>http://dx.doi.org/10.1111%2Fj.1600-0897.2011.01100.x</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Rapid and Transient Upregulation of CCL11 (Eotaxin-1) in Mouse Ovary During Terminal Stages of Follicular Development</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Yoshimitsu Kuwabara</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Akira Katayama</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Tsutomu Igarashi</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Ryoko Tomiyama</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Hua Piao</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Reika Kaneko</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Takashi Abe</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Katsuya Mine</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Shigeo Akira</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Hideo Orimo</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Toshiyuki Takeshita</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-01-06T02:18:40.582393-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/j.1600-0897.2011.01100.x</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/j.1600-0897.2011.01100.x</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1111%2Fj.1600-0897.2011.01100.x</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Original Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[<div class="section" id="aji1100-sec-0001" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Problem</h3><div class="para"><p>This study aimed to investigate the regulation of expression, localization and physiological role of the CCL11/CCR3 axis in mouse ovary during the periovulatory period.</p></div></div><div class="section" id="aji1100-sec-0002" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Method of study</h3><div class="para"><p>CCL11/CCR3 expression in the mouse ovary after treatment with pregnant mare serum gonadotropin (PMSG) followed by human chorionic gonadotropin (hCG) 48 hr later was assessed <em>in vivo</em> and in 3-dimensional cultures <em>in vitro</em>.</p></div></div><div class="section" id="aji1100-sec-0003" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Results</h3><div class="para"><p>Real-time RT-PCR analyses revealed transient CCL11 mRNA upregulation 6 hr after hCG treatment. Immunohistochemical staining of serial ovarian sections demonstrated overlapping expression of CCL11, CCR3 and CD31 endothelial cell marker in the theca-interstitial layer at 10 hr after hCG treatment. <em>In vitro</em> 3-dimensional cultures of periovulatory ovarian tissues demonstrated that treatment with anti-CCL11 neutralizing antibody significantly decreased CD31 transcript.</p></div></div><div class="section" id="aji1100-sec-0004" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Conclusions</h3><div class="para"><p>Gonadotropin surge leads to transient CCL11/CCR3 axis upregulation in the ovarian theca-interstitial layer, suggesting that it is involved in periovulatory physiological processes by affecting follicular vessels.</p></div></div>]]></content:encoded><description>ProblemThis study aimed to investigate the regulation of expression, localization and physiological role of the CCL11/CCR3 axis in mouse ovary during the periovulatory period.Method of studyCCL11/CCR3 expression in the mouse ovary after treatment with pregnant mare serum gonadotropin (PMSG) followed by human chorionic gonadotropin (hCG) 48 hr later was assessed in vivo and in 3-dimensional cultures in vitro.ResultsReal-time RT-PCR analyses revealed transient CCL11 mRNA upregulation 6 hr after hCG treatment. Immunohistochemical staining of serial ovarian sections demonstrated overlapping expression of CCL11, CCR3 and CD31 endothelial cell marker in the theca-interstitial layer at 10 hr after hCG treatment. In vitro 3-dimensional cultures of periovulatory ovarian tissues demonstrated that treatment with anti-CCL11 neutralizing antibody significantly decreased CD31 transcript.ConclusionsGonadotropin surge leads to transient CCL11/CCR3 axis upregulation in the ovarian theca-interstitial layer, suggesting that it is involved in periovulatory physiological processes by affecting follicular vessels.</description></item><item rdf:about="http://dx.doi.org/10.1111%2Fj.1600-0897.2011.01098.x" xmlns="http://purl.org/rss/1.0/"><title>Abortion-Prone Mating Influences Alteration of Systemic a2 Vacuolar ATPase Expression in Spleen and Blood Immune Cells</title><link>http://dx.doi.org/10.1111%2Fj.1600-0897.2011.01098.x</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Abortion-Prone Mating Influences Alteration of Systemic a2 Vacuolar ATPase Expression in Spleen and Blood Immune Cells</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Mukesh K. Jaiswal</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Timothy M. Mallers</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Christina Kwong</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Gerard Chaouat</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Alice Gilman-Sachs</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Kenneth D. Beaman</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-01-06T02:18:28.966137-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/j.1600-0897.2011.01098.x</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/j.1600-0897.2011.01098.x</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1111%2Fj.1600-0897.2011.01098.x</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Original Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[<div class="section" id="aji1098-sec-0001" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Problem</h3><div class="para"><p>a2 isoform of vacuolar ATPase (<span class="fixed-roman">Atp6v0a2</span>) is important for maintaining the delicate immunological balance required for successful pregnancy. The objective of this investigation is to study the dynamic changes in spleen and blood that appear during spontaneous abortion in mice.</p></div></div><div class="section" id="aji1098-sec-0002" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Method of study</h3><div class="para"><p><span class="fixed-roman">Atp6v0a2</span> was measured in multiple immune cell populations from spleen and blood recovered from non–abortion-prone and abortion-prone mating combinations.</p></div></div><div class="section" id="aji1098-sec-0003" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Results</h3><div class="para"><p><span class="fixed-roman">Atp6v0a2</span> expression was significantly lower (<em>P</em> ≤ 0.01) in the spleen recovered from abortion-prone ♀CBA × ♂DBA mating on days 12 and 16 of pregnancy when compared to non–abortion-prone ♀BALB/c × ♂BALB/c and ♀CBA × ♂BALB/c matings. Flow cytometric studies showed that significantly decreased expression of <span class="fixed-roman">Atp6v0a2</span> in splenic CD4<sup>+</sup>, CD8<sup>+</sup>, CD19<sup>+</sup>, and CD14<sup>+</sup> cells directly correlated with the high percentages of fetal resorption observed in abortion-prone mating on days 12 and 16 of pregnancy. In blood, CD4<sup>+</sup>, CD8<sup>+</sup>, and CD19<sup>+</sup> cells had a significantly reduced expression of <span class="fixed-roman">Atp6v0a2</span> in abortion-prone mating compared to the non–abortion-prone mating combinations only on day 12.</p></div></div><div class="section" id="aji1098-sec-0004" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Conclusion</h3><div class="para"><p>This deceased expression of <span class="fixed-roman">Atp6v0a2</span> in the various immune cell populations of the spleen and blood suggests that the maternal environment is not supportive to fetus and leads to poor pregnancy outcome in the abortion-prone mating model.</p></div></div>]]></content:encoded><description>Problema2 isoform of vacuolar ATPase (Atp6v0a2) is important for maintaining the delicate immunological balance required for successful pregnancy. The objective of this investigation is to study the dynamic changes in spleen and blood that appear during spontaneous abortion in mice.Method of studyAtp6v0a2 was measured in multiple immune cell populations from spleen and blood recovered from non–abortion-prone and abortion-prone mating combinations.ResultsAtp6v0a2 expression was significantly lower (P ≤ 0.01) in the spleen recovered from abortion-prone ♀CBA × ♂DBA mating on days 12 and 16 of pregnancy when compared to non–abortion-prone ♀BALB/c × ♂BALB/c and ♀CBA × ♂BALB/c matings. Flow cytometric studies showed that significantly decreased expression of Atp6v0a2 in splenic CD4+, CD8+, CD19+, and CD14+ cells directly correlated with the high percentages of fetal resorption observed in abortion-prone mating on days 12 and 16 of pregnancy. In blood, CD4+, CD8+, and CD19+ cells had a significantly reduced expression of Atp6v0a2 in abortion-prone mating compared to the non–abortion-prone mating combinations only on day 12.ConclusionThis deceased expression of Atp6v0a2 in the various immune cell populations of the spleen and blood suggests that the maternal environment is not supportive to fetus and leads to poor pregnancy outcome in the abortion-prone mating model.</description></item><item rdf:about="http://dx.doi.org/10.1111%2Fj.1600-0897.2011.01096.x" xmlns="http://purl.org/rss/1.0/"><title>Heme Oxygenase-1 Expression in the Ovary Dictates a Proper Oocyte Ovulation, Fertilization, and Corpora Lutea Maintenance</title><link>http://dx.doi.org/10.1111%2Fj.1600-0897.2011.01096.x</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Heme Oxygenase-1 Expression in the Ovary Dictates a Proper Oocyte Ovulation, Fertilization, and Corpora Lutea Maintenance</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Maria L. Zenclussen</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Federico Jensen</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Sofia Rebelo</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Tarek El-Mousleh</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Pablo A. Casalis</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Ana C. Zenclussen</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2011-12-02T05:24:23.204988-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/j.1600-0897.2011.01096.x</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/j.1600-0897.2011.01096.x</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1111%2Fj.1600-0897.2011.01096.x</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">ORIGINAL ARTICLE</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">no</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">no</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p><b>Citation</b> Zenclussen ML, Jensen F, Rebelo S, El-Mousleh T, Casalis PA, Zenclussen AC. Heme oxygenase-1 expression in the ovary dictates a proper oocyte ovulation, fertilization, and corpora lutea maintenance. Am J Reprod Immunol 2011</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Problem </b> Animals deficient in Heme oxygenase-1 (HO-1, <em>Hmox1</em><sup>−/−</sup> mice) have impaired pregnancies, characterized by intrauterine fetal death. HO-1 expression has been shown to be essential for pregnancy by dictating placentation and intrauterine fetal development. Its absence leads to intrauterine fetal growth restriction and fetal loss, which is independent of the immune system. Defect in previous steps, e.g., ovulation, may, however, also count for their poor reproductive outcome.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Method of study </b> Here, we investigated ovulation after hormonal hyperstimulation in <em>Hmox1</em> wild-type and knockout animals.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Results and Conclusions </b> We observed that animals lacking HO-1 produced significantly less oocytes after hormonal stimulation than wild type animals and this was mirrored by the number of corpora lutea in the ovary. Furthermore, ovulated oocytes from <em>Hmox1</em><sup>−/−</sup> animals were poorly fertilized compared with those from wild-type animals. In conclusion, we demonstrate here that HO-1 plays a pivotal role in the process of oocyte ovulation as well as fertilization, bringing to light a new and unsuspected role for HO-1.</p></div>]]></content:encoded><description>Citation Zenclussen ML, Jensen F, Rebelo S, El-Mousleh T, Casalis PA, Zenclussen AC. Heme oxygenase-1 expression in the ovary dictates a proper oocyte ovulation, fertilization, and corpora lutea maintenance. Am J Reprod Immunol 2011Problem  Animals deficient in Heme oxygenase-1 (HO-1, Hmox1−/− mice) have impaired pregnancies, characterized by intrauterine fetal death. HO-1 expression has been shown to be essential for pregnancy by dictating placentation and intrauterine fetal development. Its absence leads to intrauterine fetal growth restriction and fetal loss, which is independent of the immune system. Defect in previous steps, e.g., ovulation, may, however, also count for their poor reproductive outcome.Method of study  Here, we investigated ovulation after hormonal hyperstimulation in Hmox1 wild-type and knockout animals.Results and Conclusions  We observed that animals lacking HO-1 produced significantly less oocytes after hormonal stimulation than wild type animals and this was mirrored by the number of corpora lutea in the ovary. Furthermore, ovulated oocytes from Hmox1−/− animals were poorly fertilized compared with those from wild-type animals. In conclusion, we demonstrate here that HO-1 plays a pivotal role in the process of oocyte ovulation as well as fertilization, bringing to light a new and unsuspected role for HO-1.</description></item><item rdf:about="http://dx.doi.org/10.1111%2Fj.1600-0897.2011.01094.x" xmlns="http://purl.org/rss/1.0/"><title>Progesterone Modulates the Expression of Interleukin-6 in Cultured Term Human Uterine Cervical Fibroblasts</title><link>http://dx.doi.org/10.1111%2Fj.1600-0897.2011.01094.x</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Progesterone Modulates the Expression of Interleukin-6 in Cultured Term Human Uterine Cervical Fibroblasts</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Min-Gyun Kim</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Jae-Yoon Shim</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Jhang Ho Pak</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Bok-Kyung Jung</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Hye-Sung Won</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Pil-Ryang Lee</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Ahm Kim</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2011-11-29T07:20:42.850199-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/j.1600-0897.2011.01094.x</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/j.1600-0897.2011.01094.x</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1111%2Fj.1600-0897.2011.01094.x</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">ORIGINAL ARTICLE</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">no</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">no</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p><b>Citation </b>Kim M-G, Shim J-Y, Pak JH, Jung B-K, Won H-S, Lee P-R, Kim A. Progesterone modulates the expression of interleukin-6 in cultured term human uterine cervical fibroblasts. Am J Reprod Immunol 2011</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Problem </b> The preventative value of progesterone in preterm labor has been recently recognized, especially when it is administered via vaginal suppository. This study was undertaken to evaluate the effect of progesterone on interleukin-6 (IL-6) production in human uterine cervical fibroblasts (UCFs) treated with lipopolysaccharides (LPS).</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Method of study </b> Human uterine cervical tissue was obtained at term, prior to the onset of labor, during the scheduled cesarean section or cesarean hysterectomy. Primary UCF cultures were established and confirmed by immunohistochemistry. IL-6 mRNA and protein expressions were examined by reverse-transcription polymerase chain reaction and enzyme-linked immunosorbent assay, respectively.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Results </b> Lipopolysaccharides stimulation induced a clear time- and dose-dependent increase in IL-6 mRNA and protein levels in UCFs (<em>P</em> &lt; 0.05). Progesterone treatment significantly attenuated LPS-induced increases in IL-6 mRNA and protein expressions in UCFs (<em>P </em>&lt;<em> </em>0.05). Estrogen exposure had no effect on LPS-induced IL-6 up-regulation and did not modulate the effects of progesterone.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Conclusion </b> Our preliminary results suggest that vaginal progesterone might prevent spontaneous preterm labor through a mechanism involving anti-inflammatory effects on UCFs, particularly suppression of IL-6 production.</p></div>]]></content:encoded><description>Citation Kim M-G, Shim J-Y, Pak JH, Jung B-K, Won H-S, Lee P-R, Kim A. Progesterone modulates the expression of interleukin-6 in cultured term human uterine cervical fibroblasts. Am J Reprod Immunol 2011Problem  The preventative value of progesterone in preterm labor has been recently recognized, especially when it is administered via vaginal suppository. This study was undertaken to evaluate the effect of progesterone on interleukin-6 (IL-6) production in human uterine cervical fibroblasts (UCFs) treated with lipopolysaccharides (LPS).Method of study  Human uterine cervical tissue was obtained at term, prior to the onset of labor, during the scheduled cesarean section or cesarean hysterectomy. Primary UCF cultures were established and confirmed by immunohistochemistry. IL-6 mRNA and protein expressions were examined by reverse-transcription polymerase chain reaction and enzyme-linked immunosorbent assay, respectively.Results  Lipopolysaccharides stimulation induced a clear time- and dose-dependent increase in IL-6 mRNA and protein levels in UCFs (P &lt; 0.05). Progesterone treatment significantly attenuated LPS-induced increases in IL-6 mRNA and protein expressions in UCFs (P &lt; 0.05). Estrogen exposure had no effect on LPS-induced IL-6 up-regulation and did not modulate the effects of progesterone.Conclusion  Our preliminary results suggest that vaginal progesterone might prevent spontaneous preterm labor through a mechanism involving anti-inflammatory effects on UCFs, particularly suppression of IL-6 production.</description></item><item rdf:about="http://dx.doi.org/10.1111%2Fj.1600-0897.2011.01089.x" xmlns="http://purl.org/rss/1.0/"><title>Short-Chain Fatty Acids Induce Pro-Inflammatory Cytokine Production Alone and in Combination with Toll-Like Receptor Ligands</title><link>http://dx.doi.org/10.1111%2Fj.1600-0897.2011.01089.x</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Short-Chain Fatty Acids Induce Pro-Inflammatory Cytokine Production Alone and in Combination with Toll-Like Receptor Ligands</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Paria Mirmonsef</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Mohammad R. Zariffard</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Douglas Gilbert</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Hadijat Makinde</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Alan L. Landay</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Greg T. Spear</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2011-11-08T06:45:50.960904-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/j.1600-0897.2011.01089.x</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/j.1600-0897.2011.01089.x</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1111%2Fj.1600-0897.2011.01089.x</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">ORIGINAL ARTICLE</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">no</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">no</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p><b>Citation</b> Mirmonsef P, Zariffard MR, Gilbert D, Makinde H, Landay, AL, Spear GT. Short-chain fatty acids induce pro-inflammatory cytokine production alone and in combination with Toll-like receptor ligands. Am J Reprod Immunol 2011</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Problem </b> Short-chain fatty acids (SCFAs), produced at relatively high levels by anaerobic bacteria in bacterial vaginosis (BV), are believed to be anti-inflammatory. BV, a common alteration in the genital microbiota associated with increased susceptibility to HIV infection, is characterized by increased levels of both pro-inflammatory cytokines and SCFAs. We investigated how SCFAs alone or together with Toll-like receptor (TLR) ligands affected pro-inflammatory cytokine secretion.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Method of study </b> Cytokines were measured by ELISA. Flow was used for phenotyping and reactive oxygen species (ROS) measurement.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Results </b> Short-chain fatty acids, at 20 m<span class="smallCaps">m</span>, induced interleukin (IL)-8, IL-6, and IL-1β release, while lower levels (0.02–2 m<span class="smallCaps">m</span>) did not induce cytokine secretion. Levels &gt;20 m<span class="smallCaps">m</span> were toxic to cells. Interestingly, lower levels of SCFAs significantly enhanced TLR2 ligand- and TLR7 ligand-induced production of IL-8 and TNFα in a time- and dose-dependent manner, but had little effect on lipopolysaccharide-induced cytokine release. SCFAs mediated their effects on pro-inflammatory cytokine production at least in part by inducing the generation of ROS.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Conclusion </b> Our data suggest that SCFAs, especially when combined with specific TLR ligands, contribute to a pro-inflammatory milieu in the lower genital tract and help further our understanding of how BV affects susceptibility to microbial infections.</p></div>]]></content:encoded><description>Citation Mirmonsef P, Zariffard MR, Gilbert D, Makinde H, Landay, AL, Spear GT. Short-chain fatty acids induce pro-inflammatory cytokine production alone and in combination with Toll-like receptor ligands. Am J Reprod Immunol 2011Problem  Short-chain fatty acids (SCFAs), produced at relatively high levels by anaerobic bacteria in bacterial vaginosis (BV), are believed to be anti-inflammatory. BV, a common alteration in the genital microbiota associated with increased susceptibility to HIV infection, is characterized by increased levels of both pro-inflammatory cytokines and SCFAs. We investigated how SCFAs alone or together with Toll-like receptor (TLR) ligands affected pro-inflammatory cytokine secretion.Method of study  Cytokines were measured by ELISA. Flow was used for phenotyping and reactive oxygen species (ROS) measurement.Results  Short-chain fatty acids, at 20 mm, induced interleukin (IL)-8, IL-6, and IL-1β release, while lower levels (0.02–2 mm) did not induce cytokine secretion. Levels &gt;20 mm were toxic to cells. Interestingly, lower levels of SCFAs significantly enhanced TLR2 ligand- and TLR7 ligand-induced production of IL-8 and TNFα in a time- and dose-dependent manner, but had little effect on lipopolysaccharide-induced cytokine release. SCFAs mediated their effects on pro-inflammatory cytokine production at least in part by inducing the generation of ROS.Conclusion  Our data suggest that SCFAs, especially when combined with specific TLR ligands, contribute to a pro-inflammatory milieu in the lower genital tract and help further our understanding of how BV affects susceptibility to microbial infections.</description></item><item rdf:about="http://dx.doi.org/10.1111%2Fj.1600-0897.2011.01086.x" xmlns="http://purl.org/rss/1.0/"><title>Effect on the Production of Soluble Endoglin from Human Choriocarcinoma Cells by Preeclampsia Sera</title><link>http://dx.doi.org/10.1111%2Fj.1600-0897.2011.01086.x</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Effect on the Production of Soluble Endoglin from Human Choriocarcinoma Cells by Preeclampsia Sera</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Youichi Aoki</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Tatsuo Yamamoto</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Chishima Fumihisa</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Akikazu Nakamura</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Aki Asanuma</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Manami Suzuki</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2011-10-31T23:14:47.999289-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/j.1600-0897.2011.01086.x</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/j.1600-0897.2011.01086.x</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1111%2Fj.1600-0897.2011.01086.x</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">ORIGINAL ARTICLE</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">no</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">no</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p><b>Citation</b> Aoki Y, Yamamoto T, Fumihisa C, Nakamura A, Asanuma A, Suzuki M. Effect on the production of soluble endoglin from human choriocarcinoma cells by preeclampsia sera. Am J Reprod Immunol 2011</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Problem </b> The soluble endoglin (sEng) is an antiangiogenic protein that may inhibit TGF-β1 signaling and endothelial nitric oxide synthase activation in endothelial cells. The levels of sEng increased in sera obtained from preeclampsia. The factors that increase the sEng in preeclampsia have not been known well. To investigate the factors that may increase sEng in preeclampsia, we examined the effect of preeclampsia sera on the production of sEng from human choriocarcinoma (JEG-3) cells.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Methods </b> Serum samples were taken from women with normal pregnancy and from those with preeclampsia. JEG-3 cells were cultured with serum for 24 hrs, and the sEng levels in supernatants and expression of sEng and Hemo oxygenase-1 (HO-1) mRNA in cells were measured.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Results </b> The addition of preeclampsia sera into JEG-3 cells led to increased release of sEng and expression of Eng mRNA. Preeclampsia sera inhibited the expression of HO-1 mRNA in JEG-3 cells.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Conclusion </b> The results suggest that preeclampsia sera may increase the protein production of sEng and mRNA expression of Eng from JEG-3 cells like trophoblast without hypoxia and that in addition to hypoxia, preeclampsia sera may play a role of high level of serum sEng in preeclampsia patients. Decreased HO-1 activity may relate to increased sEng release.</p></div>]]></content:encoded><description>Citation Aoki Y, Yamamoto T, Fumihisa C, Nakamura A, Asanuma A, Suzuki M. Effect on the production of soluble endoglin from human choriocarcinoma cells by preeclampsia sera. Am J Reprod Immunol 2011Problem  The soluble endoglin (sEng) is an antiangiogenic protein that may inhibit TGF-β1 signaling and endothelial nitric oxide synthase activation in endothelial cells. The levels of sEng increased in sera obtained from preeclampsia. The factors that increase the sEng in preeclampsia have not been known well. To investigate the factors that may increase sEng in preeclampsia, we examined the effect of preeclampsia sera on the production of sEng from human choriocarcinoma (JEG-3) cells.Methods  Serum samples were taken from women with normal pregnancy and from those with preeclampsia. JEG-3 cells were cultured with serum for 24 hrs, and the sEng levels in supernatants and expression of sEng and Hemo oxygenase-1 (HO-1) mRNA in cells were measured.Results  The addition of preeclampsia sera into JEG-3 cells led to increased release of sEng and expression of Eng mRNA. Preeclampsia sera inhibited the expression of HO-1 mRNA in JEG-3 cells.Conclusion  The results suggest that preeclampsia sera may increase the protein production of sEng and mRNA expression of Eng from JEG-3 cells like trophoblast without hypoxia and that in addition to hypoxia, preeclampsia sera may play a role of high level of serum sEng in preeclampsia patients. Decreased HO-1 activity may relate to increased sEng release.</description></item><item rdf:about="http://dx.doi.org/10.1111%2Fj.1600-0897.2011.01087.x" xmlns="http://purl.org/rss/1.0/"><title>Follicular Dynamic and Immunoreactions of the Vitrified Ovarian Graft After Host Treatment with Variable Regimens of Melatonin</title><link>http://dx.doi.org/10.1111%2Fj.1600-0897.2011.01087.x</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Follicular Dynamic and Immunoreactions of the Vitrified Ovarian Graft After Host Treatment with Variable Regimens of Melatonin</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Masoud Hemadi</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Saeed Shokri</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Elham Pourmatroud</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Farideh Moramezi</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Ali Khodadai</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2011-10-30T20:34:51.84411-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/j.1600-0897.2011.01087.x</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/j.1600-0897.2011.01087.x</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1111%2Fj.1600-0897.2011.01087.x</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">ORIGINAL ARTICLE</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">no</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">no</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p><b>Citation</b>  Hemadi M, Shokri S, Pourmatroud E, Moramezi F, Khodadai A. Follicular dynamic and immunoreactions of the vitrified ovarian graft after host treatment with variable regimens of melatonin. Am J Reprod Immunol 2011</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Problem </b> This study investigates dose-dependent effects of melatonin on ovarian graft.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Method of Study </b> Vitrified-thawed whole ovaries of newborn mice were grafted into ovariectomized mature ones. Melatonin (20, 50, 100, and 200 mg/kg/day) was administrated to separate groups of host mice for 32 days. IgM and IgG antibodies, Th1 and Th2 cytokines, and melatonin in recipient’s blood were measured. Subsequent survival of the grafted ovaries was scored. An assessment of follicular morphology was performed using TUNEL assay and hematoxylin-eosin staining.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Results </b> The administration of melatonin did not disturb the circadian rhythm of melatonin concentration. The ovarian graft lifespan was prolonged at 200 mg/kg/day melatonin (<em>P </em>&lt; 0.001). However, in doses of higher than 20 mg/kg/day melatonin, the proportion of healthy follicles and ovary size decreased. Th1 cytokines levels were reduced dose dependently. However, the effect of melatonin on Th2 cytokines was not pronounced. IgM and IgG2a decreased in recipients receiving 200 mg/kg/day melatonin in comparison with non-treated group (<em>P </em>&lt; 0.001), while this variables were significantly increased at the dose of 50 mg/kg/day (<em>P </em>&lt; 0.001).</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Conclusion </b> Melatonin at 200 mg/kg/day has an immunosuppresent effect and produce prolongation of graft survival. However, the associated reduction in healthy follicles suggests that melatonin in doses of higher than 20 mg/kg/day has no preventative ischemic action.</p></div>]]></content:encoded><description>Citation  Hemadi M, Shokri S, Pourmatroud E, Moramezi F, Khodadai A. Follicular dynamic and immunoreactions of the vitrified ovarian graft after host treatment with variable regimens of melatonin. Am J Reprod Immunol 2011Problem  This study investigates dose-dependent effects of melatonin on ovarian graft.Method of Study  Vitrified-thawed whole ovaries of newborn mice were grafted into ovariectomized mature ones. Melatonin (20, 50, 100, and 200 mg/kg/day) was administrated to separate groups of host mice for 32 days. IgM and IgG antibodies, Th1 and Th2 cytokines, and melatonin in recipient’s blood were measured. Subsequent survival of the grafted ovaries was scored. An assessment of follicular morphology was performed using TUNEL assay and hematoxylin-eosin staining.Results  The administration of melatonin did not disturb the circadian rhythm of melatonin concentration. The ovarian graft lifespan was prolonged at 200 mg/kg/day melatonin (P &lt; 0.001). However, in doses of higher than 20 mg/kg/day melatonin, the proportion of healthy follicles and ovary size decreased. Th1 cytokines levels were reduced dose dependently. However, the effect of melatonin on Th2 cytokines was not pronounced. IgM and IgG2a decreased in recipients receiving 200 mg/kg/day melatonin in comparison with non-treated group (P &lt; 0.001), while this variables were significantly increased at the dose of 50 mg/kg/day (P &lt; 0.001).Conclusion  Melatonin at 200 mg/kg/day has an immunosuppresent effect and produce prolongation of graft survival. However, the associated reduction in healthy follicles suggests that melatonin in doses of higher than 20 mg/kg/day has no preventative ischemic action.</description></item><item rdf:about="http://dx.doi.org/10.1111%2Fj.1600-0897.2011.01081.x" xmlns="http://purl.org/rss/1.0/"><title>Negative Emotions and Cytokines in Maternal and Cord Serum at Preterm Birth</title><link>http://dx.doi.org/10.1111%2Fj.1600-0897.2011.01081.x</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Negative Emotions and Cytokines in Maternal and Cord Serum at Preterm Birth</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Emma Fransson</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Aurelija Dubicke</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Birgitta Byström</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Gunvor Ekman-Ordeberg</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Anna Hjelmstedt</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Mats Lekander</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2011-10-21T09:54:52.619615-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/j.1600-0897.2011.01081.x</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/j.1600-0897.2011.01081.x</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1111%2Fj.1600-0897.2011.01081.x</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">ORIGINAL ARTICLE</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">no</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">no</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p><b>Citation</b> Fransson E, Dubicke A, Byström B, Ekman-Ordeberg G, Hjelmstedt A, Lekander M. Negative emotions and cytokines in maternal and cord serum at preterm birth. Am J Reprod Immunol 2011</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Problem </b> This study investigates whether affectivity differs between mothers delivering preterm and term and whether maternal and umbilical cord serum cytokines differ between these groups. Further, whether there are associations between mothers’ emotions and maternal and cord cytokines at preterm and term birth.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Method of study </b> Twenty-seven mothers delivering preterm and 37 mothers delivering at term reported positive/negative affect and previous depressive symptoms during pregnancy. Blood samples from mothers in labor and cord samples (23 preterm and 33 term) were analyzed for cytokines.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Results </b> Maternal IL-8 was lower at preterm delivery compared with term. In the preterm group only, associations were found between negative emotions and maternal IL-6, IL-8 and cord IL-6, IL-8, IL-10, IL-13, and IL-18.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Conclusion </b> The findings indicate associations in preterm delivery between negative emotions and both maternal and neonate immune activity. Future studies should investigate whether such associations are part of the etiology of preterm delivery.</p></div>]]></content:encoded><description>Citation Fransson E, Dubicke A, Byström B, Ekman-Ordeberg G, Hjelmstedt A, Lekander M. Negative emotions and cytokines in maternal and cord serum at preterm birth. Am J Reprod Immunol 2011Problem  This study investigates whether affectivity differs between mothers delivering preterm and term and whether maternal and umbilical cord serum cytokines differ between these groups. Further, whether there are associations between mothers’ emotions and maternal and cord cytokines at preterm and term birth.Method of study  Twenty-seven mothers delivering preterm and 37 mothers delivering at term reported positive/negative affect and previous depressive symptoms during pregnancy. Blood samples from mothers in labor and cord samples (23 preterm and 33 term) were analyzed for cytokines.Results  Maternal IL-8 was lower at preterm delivery compared with term. In the preterm group only, associations were found between negative emotions and maternal IL-6, IL-8 and cord IL-6, IL-8, IL-10, IL-13, and IL-18.Conclusion  The findings indicate associations in preterm delivery between negative emotions and both maternal and neonate immune activity. Future studies should investigate whether such associations are part of the etiology of preterm delivery.</description></item><item rdf:about="http://dx.doi.org/10.1111%2Fj.1600-0897.2011.01071.x" xmlns="http://purl.org/rss/1.0/"><title>Analysis of the Potential Role of Apolipoprotein E Polymorphism in Genetic Predisposition to Spontaneous Abortion</title><link>http://dx.doi.org/10.1111%2Fj.1600-0897.2011.01071.x</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Analysis of the Potential Role of Apolipoprotein E Polymorphism in Genetic Predisposition to Spontaneous Abortion</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Jitka Rynekrova</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Dita Kasparova</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Vera Adamkova</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Tomas Fait</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Jaroslav A. Hubacek</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-03-01T00:00:00-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/j.1600-0897.2011.01071.x</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/j.1600-0897.2011.01071.x</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1111%2Fj.1600-0897.2011.01071.x</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">SHORT COMMUNICATION</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">179</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">183</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p><b>Citation</b> Rynekrova J, Kasparova D, Adamkova V, Fait T, Hubacek JA. Analysis of the potential role of apolipoprotein E polymorphism in genetic predisposition to spontaneous abortion. Am J Reprod Immunol 2012; 67: 179–183</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Problem </b> Up to 20% of pregnancies end in the first trimester by spontaneous abortion, but a significant number remains unexplained. The aim of this study is to investigate the role of variants within the gene for apolipoprotein E (<em>APOE</em>) in the genetic determination of spontaneous abortions.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Method of study </b> We collected DNA from 410 tissue samples of spontaneous abortions, and <em>APOE</em> was genotyped by PCR–RFLP method. The frequencies were compared with a population sample of adults (<em>N</em> = 2606) and with a positive control (1060 women with at least two children).</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Results </b> The frequencies of the <em>APOE</em> genotypes in abortions (<em>APOE2E2 </em>+<em> E3E2 </em>=<em> </em>0.132; <em>APOE3E3 </em>=<em> </em>0.661; <em>APOE3E4 </em>+<em> E4E4 </em>=<em> </em>0.195; <em>APOE4E2 </em>=<em> </em>0.012) did not significantly differ (<em>P</em> = 0.604) from the frequencies in analyzed adult population study (<em>APOE2E2 </em>+<em> E3E2 </em>=<em> </em>0.132; <em>APOE3E3 </em>=<em> </em>0.686; <em>APOE3E4 </em>+<em> E4E4 </em>=<em> </em>0.169; <em>APOE4E2 </em>=<em> </em>0.014) or from the positive control (<em>APOE2E2 </em>+<em> E3E2 </em>=<em> </em>0.133; <em>APOE3E3 </em>=<em> </em>0.691; <em>APOE3E4 </em>+<em> E4E4 </em>=0.166; <em>APOE4E2 </em>=<em> </em>0.010; <em>P</em> = 0.592).</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Conclusion </b> Our study suggests that <em>APOE</em> may not be associated with spontaneous abortions in Caucasians.</p></div>]]></content:encoded><description>Citation Rynekrova J, Kasparova D, Adamkova V, Fait T, Hubacek JA. Analysis of the potential role of apolipoprotein E polymorphism in genetic predisposition to spontaneous abortion. Am J Reprod Immunol 2012; 67: 179–183Problem  Up to 20% of pregnancies end in the first trimester by spontaneous abortion, but a significant number remains unexplained. The aim of this study is to investigate the role of variants within the gene for apolipoprotein E (APOE) in the genetic determination of spontaneous abortions.Method of study  We collected DNA from 410 tissue samples of spontaneous abortions, and APOE was genotyped by PCR–RFLP method. The frequencies were compared with a population sample of adults (N = 2606) and with a positive control (1060 women with at least two children).Results  The frequencies of the APOE genotypes in abortions (APOE2E2 + E3E2 = 0.132; APOE3E3 = 0.661; APOE3E4 + E4E4 = 0.195; APOE4E2 = 0.012) did not significantly differ (P = 0.604) from the frequencies in analyzed adult population study (APOE2E2 + E3E2 = 0.132; APOE3E3 = 0.686; APOE3E4 + E4E4 = 0.169; APOE4E2 = 0.014) or from the positive control (APOE2E2 + E3E2 = 0.133; APOE3E3 = 0.691; APOE3E4 + E4E4 =0.166; APOE4E2 = 0.010; P = 0.592).Conclusion  Our study suggests that APOE may not be associated with spontaneous abortions in Caucasians.</description></item><item rdf:about="http://dx.doi.org/10.1111%2Fj.1600-0897.2011.01088.x" xmlns="http://purl.org/rss/1.0/"><title>Peripheral CD300a+CD8+ T Lymphocytes with a Distinct Cytotoxic Molecular Signature Increase in Pregnant Women with Chronic Chorioamnionitis</title><link>http://dx.doi.org/10.1111%2Fj.1600-0897.2011.01088.x</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Peripheral CD300a+CD8+ T Lymphocytes with a Distinct Cytotoxic Molecular Signature Increase in Pregnant Women with Chronic Chorioamnionitis</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Yi Xu</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Federica Tarquini</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Roberto Romero</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Chong Jai Kim</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Adi L. Tarca</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Gaurav Bhatti</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">JoonHo Lee</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">I. Birgitta Sundell</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Pooja Mittal</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Juan Pedro Kusanovic</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Sonia S. Hassan</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Jung-Sun Kim</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-03-01T00:00:00-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/j.1600-0897.2011.01088.x</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/j.1600-0897.2011.01088.x</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1111%2Fj.1600-0897.2011.01088.x</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">ORIGINAL ARTICLE</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">184</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">197</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p><b>Citation</b> Xu Y, Tarquini F, Romero R, Kim CJ, Tarca AL, Bhatti G, Lee J, Sundell IB, Mittal P, Kusanovic JP, Hassan SS, Kim J-S. Peripheral CD300a+CD8+ T lymphocytes with a distinct cytotoxic molecular signature increase in pregnant women with chronic chorioamnionitis. Am J Reprod Immunol 2012; 67: 184–197</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Problem </b> CD300a is an immunomodulatory molecule of the immunoglobulin receptor superfamily expressed in the leukocytes of myeloid and lymphoid lineages. However, its biological function on CD8+ T lymphocytes remains largely unknown. This study was conducted to assess the biological significance of CD300a expression in T lymphocytes and to determine whether its expression in peripheral T lymphocytes changes in pregnant women presenting with antifetal rejection.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Methods of Study </b> Microarray analysis was performed using total RNA isolated from peripheral CD300a+ and CD300a− T lymphocytes. Flow cytometric analysis of the peripheral blood samples of pregnant women and pathologic examination of the placentas were conducted.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Results </b> A large number of genes (<em>N</em> = 1245) were differentially expressed between CD300a− and CD300a+ subsets of CD8+ T lymphocytes, which included CCR7, CD244, CX3CR1, GLNY, GZMB, GZMK, IL15, ITGB1, KLRG1, PRF1, and SLAMF7. Gene ontology analysis of differentially expressed genes demonstrated enrichment of biological processes such as immune response, cell death, and signal transduction. CD300a expression in CD8+ T lymphocytes was coupled to a more cytotoxic molecular signature. Of note, the proportion of CD300a+CD8+ T lymphocytes increased in pregnant women with chronic chorioamnionitis (antifetal rejection of the chorioamniotic membranes; <em>P</em> &lt; 0.05).</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Conclusion </b> The findings of this study strongly suggest an increase in systemic T-lymphocyte-mediated cytotoxicity in pregnant women with chronic chorioamnionitis as a manifestation of maternal antifetal rejection.</p></div>]]></content:encoded><description>Citation Xu Y, Tarquini F, Romero R, Kim CJ, Tarca AL, Bhatti G, Lee J, Sundell IB, Mittal P, Kusanovic JP, Hassan SS, Kim J-S. Peripheral CD300a+CD8+ T lymphocytes with a distinct cytotoxic molecular signature increase in pregnant women with chronic chorioamnionitis. Am J Reprod Immunol 2012; 67: 184–197Problem  CD300a is an immunomodulatory molecule of the immunoglobulin receptor superfamily expressed in the leukocytes of myeloid and lymphoid lineages. However, its biological function on CD8+ T lymphocytes remains largely unknown. This study was conducted to assess the biological significance of CD300a expression in T lymphocytes and to determine whether its expression in peripheral T lymphocytes changes in pregnant women presenting with antifetal rejection.Methods of Study  Microarray analysis was performed using total RNA isolated from peripheral CD300a+ and CD300a− T lymphocytes. Flow cytometric analysis of the peripheral blood samples of pregnant women and pathologic examination of the placentas were conducted.Results  A large number of genes (N = 1245) were differentially expressed between CD300a− and CD300a+ subsets of CD8+ T lymphocytes, which included CCR7, CD244, CX3CR1, GLNY, GZMB, GZMK, IL15, ITGB1, KLRG1, PRF1, and SLAMF7. Gene ontology analysis of differentially expressed genes demonstrated enrichment of biological processes such as immune response, cell death, and signal transduction. CD300a expression in CD8+ T lymphocytes was coupled to a more cytotoxic molecular signature. Of note, the proportion of CD300a+CD8+ T lymphocytes increased in pregnant women with chronic chorioamnionitis (antifetal rejection of the chorioamniotic membranes; P &lt; 0.05).Conclusion  The findings of this study strongly suggest an increase in systemic T-lymphocyte-mediated cytotoxicity in pregnant women with chronic chorioamnionitis as a manifestation of maternal antifetal rejection.</description></item><item rdf:about="http://dx.doi.org/10.1111%2Fj.1600-0897.2011.01093.x" xmlns="http://purl.org/rss/1.0/"><title>Identification of Immune Cells by Flow Cytometry in Vaginal Lavages from Women with Vulvovaginitis and Normal Microflora</title><link>http://dx.doi.org/10.1111%2Fj.1600-0897.2011.01093.x</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Identification of Immune Cells by Flow Cytometry in Vaginal Lavages from Women with Vulvovaginitis and Normal Microflora</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Paulo César Giraldo</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Joziani Beghini Junqueira de Carvalho</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Rose Luce Gomes do Amaral</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Ana Katherine da Silveira Gonçalves</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">José Eleutério</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Fernando Guimarães</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-03-01T00:00:00-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/j.1600-0897.2011.01093.x</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/j.1600-0897.2011.01093.x</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1111%2Fj.1600-0897.2011.01093.x</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">ORIGINAL ARTICLE</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">198</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">205</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p><b>Citation</b> Giraldo PC, de Carvalho JBJ, do Amaral RLG, da Silveira Gonçalves AK, Eleutério J Jr, Guimarães F. Identification of Immune Cells by Flow Cytometry in Vaginal Lavages from Women with Vulvovaginitis and Normal Microflora. Am J Reprod Immunol 2012; 67: 198–205</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Problem </b> The extent of the vaginal immune response is not fully determined. The purpose of this study was to evaluate the vaginal immune cells from women with vulvovaginitis (VV).</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Method of Study </b> A total of 142 volunteers diagnosed with bacterial vaginosis (BV), vulvovaginal candidiasis (VC), and BV associated with VC or normal microflora were sampled to evaluate the immune cells by flow cytometry. The immune cells were obtained by vaginal lavage and labeled with fluorochrome-conjugated monoclonal antibodies to identify neutrophil granulocytes, macrophages, CD4<sup>+</sup> and CD8<sup>+</sup> T lymphocytes, B lymphocytes, and NK lymphocytes.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Results </b> Neutrophil granulocytes were present in 84.6% of samples among the leukocyte populations. Considering samples in which neutrophils were present, the mean percentage of neutrophil granulocytes was significantly higher in women with VC than BV and normal microflora and was significantly lower in women with BV than normal microflora. Macrophages and lymphocytes were present in a lower percentage of samples. The mean percentage of CD4<sup>+</sup> T lymphocytes in vaginal lavages was significantly higher in VC and BV compared with women with normal microflora.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Conclusions </b> Neutrophils were the predominant leukocytes and were associated with VC and inversely with BV. CD4<sup>+</sup> T lymphocytes were associated with both VC and BV.</p></div>]]></content:encoded><description>Citation Giraldo PC, de Carvalho JBJ, do Amaral RLG, da Silveira Gonçalves AK, Eleutério J Jr, Guimarães F. Identification of Immune Cells by Flow Cytometry in Vaginal Lavages from Women with Vulvovaginitis and Normal Microflora. Am J Reprod Immunol 2012; 67: 198–205Problem  The extent of the vaginal immune response is not fully determined. The purpose of this study was to evaluate the vaginal immune cells from women with vulvovaginitis (VV).Method of Study  A total of 142 volunteers diagnosed with bacterial vaginosis (BV), vulvovaginal candidiasis (VC), and BV associated with VC or normal microflora were sampled to evaluate the immune cells by flow cytometry. The immune cells were obtained by vaginal lavage and labeled with fluorochrome-conjugated monoclonal antibodies to identify neutrophil granulocytes, macrophages, CD4+ and CD8+ T lymphocytes, B lymphocytes, and NK lymphocytes.Results  Neutrophil granulocytes were present in 84.6% of samples among the leukocyte populations. Considering samples in which neutrophils were present, the mean percentage of neutrophil granulocytes was significantly higher in women with VC than BV and normal microflora and was significantly lower in women with BV than normal microflora. Macrophages and lymphocytes were present in a lower percentage of samples. The mean percentage of CD4+ T lymphocytes in vaginal lavages was significantly higher in VC and BV compared with women with normal microflora.Conclusions  Neutrophils were the predominant leukocytes and were associated with VC and inversely with BV. CD4+ T lymphocytes were associated with both VC and BV.</description></item><item rdf:about="http://dx.doi.org/10.1111%2Fj.1600-0897.2011.01079.x" xmlns="http://purl.org/rss/1.0/"><title>Microparticles of Pregnant Women and Preeclamptic Patients Activate Endothelial Cells in the Presence of Monocytes</title><link>http://dx.doi.org/10.1111%2Fj.1600-0897.2011.01079.x</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Microparticles of Pregnant Women and Preeclamptic Patients Activate Endothelial Cells in the Presence of Monocytes</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Christine A. R. Lok</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Karin S. Snijder</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Rienk Nieuwland</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Joris A. M. Van Der Post</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Paul de Vos</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Marijke M. Faas</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-03-01T00:00:00-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/j.1600-0897.2011.01079.x</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/j.1600-0897.2011.01079.x</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1111%2Fj.1600-0897.2011.01079.x</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">ORIGINAL ARTICLE</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">206</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">215</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p><b>Citation</b> Lok CAR, Snijder KS, Nieuwland R, Van Der Post JAM, de Vos P, Faas MM. Microparticles of pregnant women and preeclamptic patients activate endothelial cells in the presence of monocytes. Am J Reprod Immunol 2012; 67: 206–215</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Problem </b> Preeclampsia is a pregnancy-specific disorder that may result from an adverse maternal response to circulating placenta-derived factors, causing a systemic inflammation including endothelial activation. Plasma from preeclamptic patients was shown to induce endothelial activation in the presence of monocytes. We investigated whether microparticles (MP) are the plasma factors causing this activation of endothelial cells.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Method of study </b> Monocultures and co-cultures of monocytes and endothelial cells were incubated with plasma, MP-poor plasma or isolated MP from non-pregnant and pregnant women and preeclamptic patients (each <em>n</em> = 8). ICAM-1 expression was analyzed with flow cytometry.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Results </b> The expression of ICAM-1 was significantly increased in monocytes and endothelial cells in co-cultures after the addition of isolated MP from preeclamptic patients (<em>P</em> = 0.017) and to a lesser extent in pregnant women (<em>P</em> = 0.012) compared to non-pregnant controls.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Conclusions </b> Microparticles from preeclamptic patients activate endothelial cells in the presence of monocytes. Whether all MP have the same effect on monocytes and endothelial cells or only a specific subgroup is the focus of future research.</p></div>]]></content:encoded><description>Citation Lok CAR, Snijder KS, Nieuwland R, Van Der Post JAM, de Vos P, Faas MM. Microparticles of pregnant women and preeclamptic patients activate endothelial cells in the presence of monocytes. Am J Reprod Immunol 2012; 67: 206–215Problem  Preeclampsia is a pregnancy-specific disorder that may result from an adverse maternal response to circulating placenta-derived factors, causing a systemic inflammation including endothelial activation. Plasma from preeclamptic patients was shown to induce endothelial activation in the presence of monocytes. We investigated whether microparticles (MP) are the plasma factors causing this activation of endothelial cells.Method of study  Monocultures and co-cultures of monocytes and endothelial cells were incubated with plasma, MP-poor plasma or isolated MP from non-pregnant and pregnant women and preeclamptic patients (each n = 8). ICAM-1 expression was analyzed with flow cytometry.Results  The expression of ICAM-1 was significantly increased in monocytes and endothelial cells in co-cultures after the addition of isolated MP from preeclamptic patients (P = 0.017) and to a lesser extent in pregnant women (P = 0.012) compared to non-pregnant controls.Conclusions  Microparticles from preeclamptic patients activate endothelial cells in the presence of monocytes. Whether all MP have the same effect on monocytes and endothelial cells or only a specific subgroup is the focus of future research.</description></item><item rdf:about="http://dx.doi.org/10.1111%2Fj.1600-0897.2011.01080.x" xmlns="http://purl.org/rss/1.0/"><title>CYR61 Modulates the Vascular Endothelial Growth Factor C Expression of Decidual NK Cells Via PI3K/AKT Pathway</title><link>http://dx.doi.org/10.1111%2Fj.1600-0897.2011.01080.x</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">CYR61 Modulates the Vascular Endothelial Growth Factor C Expression of Decidual NK Cells Via PI3K/AKT Pathway</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Xindong Zhang</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Lijun Ding</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Zhenyu Diao</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Guijun Yan</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Haixiang Sun</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Yali Hu</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-03-01T00:00:00-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/j.1600-0897.2011.01080.x</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/j.1600-0897.2011.01080.x</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1111%2Fj.1600-0897.2011.01080.x</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">ORIGINAL ARTICLE</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">216</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">223</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p><b>Citation</b> Zhang X, Ding L, Diao Z, Yan G, Sun H, Hu Y. CYR61 modulates the vascular endothelial growth factor C expression of decidual NK cells via PI3K/AKT pathway. Am J Reprod Immunol 2012; 67: 216–223</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Problem </b> Either vascular endothelial growth factor C (VEGFC) or CYR61 plays an important role in placental development and may be involved in pre-eclampsia. Decidual natural killer (dNK) cells are the main source of VEGFC in the maternal–fetal interface. However, it is unclear about CYR61 on the regulation of VEGFC secretion in dNK cells.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Method of study </b> Decidual natural killer cells were isolated from decidual tissues of first trimester of pregnancy with anti-human CD56–conjugated microbeads. Integrin αvβ3 was detected using immunofluorescent staining. dNK cells were cultured in the presence of CYR61, anti-human αvβ3 integrin antibody (LM609), PI3K inhibitor (LY294002), or MEK inhibitor (U0126). VEGFC mRNA and protein were evaluated by real-time PCR and ELISA, respectively.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Results </b> Exogenous CYR61 induced the expression of VEGFC in dNK cells in both mRNA and protein levels. Integrin αvβ3 was strongly expressed on dNK cell surface. Anti-αvβ3 integrin antibody inhibited the effect of CYR61 on VEGFC expression. LY294002, but not U0126, significantly reduced this promotion effect of CYR61 on dNK cells.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Conclusions </b> The upregulation of VEGFC secretion mainly depends on CYR61 binding with integrin αvβ3 on the surface of dNK cells. PI3K/AKT, rather than the ERK/MAPK signal, is involved in the regulation.</p></div>]]></content:encoded><description>Citation Zhang X, Ding L, Diao Z, Yan G, Sun H, Hu Y. CYR61 modulates the vascular endothelial growth factor C expression of decidual NK cells via PI3K/AKT pathway. Am J Reprod Immunol 2012; 67: 216–223Problem  Either vascular endothelial growth factor C (VEGFC) or CYR61 plays an important role in placental development and may be involved in pre-eclampsia. Decidual natural killer (dNK) cells are the main source of VEGFC in the maternal–fetal interface. However, it is unclear about CYR61 on the regulation of VEGFC secretion in dNK cells.Method of study  Decidual natural killer cells were isolated from decidual tissues of first trimester of pregnancy with anti-human CD56–conjugated microbeads. Integrin αvβ3 was detected using immunofluorescent staining. dNK cells were cultured in the presence of CYR61, anti-human αvβ3 integrin antibody (LM609), PI3K inhibitor (LY294002), or MEK inhibitor (U0126). VEGFC mRNA and protein were evaluated by real-time PCR and ELISA, respectively.Results  Exogenous CYR61 induced the expression of VEGFC in dNK cells in both mRNA and protein levels. Integrin αvβ3 was strongly expressed on dNK cell surface. Anti-αvβ3 integrin antibody inhibited the effect of CYR61 on VEGFC expression. LY294002, but not U0126, significantly reduced this promotion effect of CYR61 on dNK cells.Conclusions  The upregulation of VEGFC secretion mainly depends on CYR61 binding with integrin αvβ3 on the surface of dNK cells. PI3K/AKT, rather than the ERK/MAPK signal, is involved in the regulation.</description></item><item rdf:about="http://dx.doi.org/10.1111%2Fj.1600-0897.2011.01085.x" xmlns="http://purl.org/rss/1.0/"><title>Two-Way Calf to Dam Major Histocompatibility Class I Compatibility Increases Risk for Retained Placenta in Cattle</title><link>http://dx.doi.org/10.1111%2Fj.1600-0897.2011.01085.x</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Two-Way Calf to Dam Major Histocompatibility Class I Compatibility Increases Risk for Retained Placenta in Cattle</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Lindert Benedictus</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Aaron J. Thomas</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Ruurd Jorritsma</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Christopher J. Davies</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Ad P. Koets</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-03-01T00:00:00-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/j.1600-0897.2011.01085.x</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/j.1600-0897.2011.01085.x</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1111%2Fj.1600-0897.2011.01085.x</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">ORIGINAL ARTICLE</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">224</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">230</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p><b>Citation</b>  Benedictus L, Thomas AJ, Jorritsma R, Davies CJ, Koets AP. Two-way calf to dam major histocompatibility class I compatibility increases risk for retained placenta in cattle. Am J Reprod Immunol 2012; 67: 224–230</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Problem </b> In cattle, retained placenta (RP) is suggested to arise from failure of immune-mediated rejection of the fetal membranes by the maternal immune system and is associated with major histocompatibility (MHC) class I compatibility between calf and dam.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Method of study </b> To study the association between RP and different MHC class I compatibilities between calf–dam–granddam combinations, massively parallel pyrosequencing was used to determine the MHC class I haplotypes of cows with and without RP.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Results </b> Two-way calf to dam MHC class I compatibility gave a high risk for RP. There was a tendency for a higher risk for RP with calf to dam MHC class I compatibility.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Conclusions </b> We concluded that in two-way compatible pregnancies, the maternal immune system fails to reject the fetal membranes, and the fetal immune system does not mount an immune response against maternal MHC class I antigens that could influence the immune-mediated rejection of the fetal membranes by the maternal immune system. The lack of immune-mediated rejection of the fetal membranes by the maternal immune system increases the risk of occurrence of RP.</p></div>]]></content:encoded><description>Citation  Benedictus L, Thomas AJ, Jorritsma R, Davies CJ, Koets AP. Two-way calf to dam major histocompatibility class I compatibility increases risk for retained placenta in cattle. Am J Reprod Immunol 2012; 67: 224–230Problem  In cattle, retained placenta (RP) is suggested to arise from failure of immune-mediated rejection of the fetal membranes by the maternal immune system and is associated with major histocompatibility (MHC) class I compatibility between calf and dam.Method of study  To study the association between RP and different MHC class I compatibilities between calf–dam–granddam combinations, massively parallel pyrosequencing was used to determine the MHC class I haplotypes of cows with and without RP.Results  Two-way calf to dam MHC class I compatibility gave a high risk for RP. There was a tendency for a higher risk for RP with calf to dam MHC class I compatibility.Conclusions  We concluded that in two-way compatible pregnancies, the maternal immune system fails to reject the fetal membranes, and the fetal immune system does not mount an immune response against maternal MHC class I antigens that could influence the immune-mediated rejection of the fetal membranes by the maternal immune system. The lack of immune-mediated rejection of the fetal membranes by the maternal immune system increases the risk of occurrence of RP.</description></item><item rdf:about="http://dx.doi.org/10.1111%2Fj.1600-0897.2011.01082.x" xmlns="http://purl.org/rss/1.0/"><title>Identification of Sex-Determining Region Y (SRY) in Maternal Plasma after Paternal Lymphocyte Immunization: Is it Possible?</title><link>http://dx.doi.org/10.1111%2Fj.1600-0897.2011.01082.x</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Identification of Sex-Determining Region Y (SRY) in Maternal Plasma after Paternal Lymphocyte Immunization: Is it Possible?</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Isabela N. Machado</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">José E. Levi</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Simone B. S. Lima</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Ricardo Barini</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-03-01T00:00:00-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/j.1600-0897.2011.01082.x</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/j.1600-0897.2011.01082.x</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1111%2Fj.1600-0897.2011.01082.x</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">ORIGINAL ARTICLE</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">231</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">234</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p><b>Citation</b> Machado IN, Levi JE, Lima SBS, Barini R. Identification of Sex-Determining Region Y (SRY) in Maternal Plasma after Paternal Lymphocyte Immunization: Is it Possible? Am J Reprod Immunol 2012; 67: 231–234</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Problem </b> Women treated with allogeneic immunization using paternal lymphocytes often request laboratory molecular tests using cell-free fetal DNA in maternal plasma. There is concern whether the treatment can interfere with its results. This study evaluated the applicability of fetal sex determination using fragments of sex-determining region Y (SRY) in the plasma of women submitted to paternal lymphocyte immunization.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Method of study </b> Non-pregnant women blood samples were collected at two different moments: prior to paternal lymphocyte immunization and after three doses of the immunotherapy, in a prospective study. For women who became pregnant, another sample was collect during the first trimester. Amplification of the fragment of the Y chromosome (SRY) was performed using real-time PCR.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Results </b> The SRY gene was not identified in any of the plasma samples of the 50 non-pregnant women submitted to paternal lymphocyte immunization at either of the two moments evaluated. For the 26 pregnant women, the results of the identification of sex -determining in maternal plasma were completely in agreement with the infant sex.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Conclusion </b> Paternal lymphocyte immunization does not affect the results of SRY fragment investigation in the plasma of women submitted to paternal lymphocyte immunization therapy.</p></div>]]></content:encoded><description>Citation Machado IN, Levi JE, Lima SBS, Barini R. Identification of Sex-Determining Region Y (SRY) in Maternal Plasma after Paternal Lymphocyte Immunization: Is it Possible? Am J Reprod Immunol 2012; 67: 231–234Problem  Women treated with allogeneic immunization using paternal lymphocytes often request laboratory molecular tests using cell-free fetal DNA in maternal plasma. There is concern whether the treatment can interfere with its results. This study evaluated the applicability of fetal sex determination using fragments of sex-determining region Y (SRY) in the plasma of women submitted to paternal lymphocyte immunization.Method of study  Non-pregnant women blood samples were collected at two different moments: prior to paternal lymphocyte immunization and after three doses of the immunotherapy, in a prospective study. For women who became pregnant, another sample was collect during the first trimester. Amplification of the fragment of the Y chromosome (SRY) was performed using real-time PCR.Results  The SRY gene was not identified in any of the plasma samples of the 50 non-pregnant women submitted to paternal lymphocyte immunization at either of the two moments evaluated. For the 26 pregnant women, the results of the identification of sex -determining in maternal plasma were completely in agreement with the infant sex.Conclusion  Paternal lymphocyte immunization does not affect the results of SRY fragment investigation in the plasma of women submitted to paternal lymphocyte immunization therapy.</description></item><item rdf:about="http://dx.doi.org/10.1111%2Fj.1600-0897.2011.01084.x" xmlns="http://purl.org/rss/1.0/"><title>Interleukin-6 as a Predictor of Subclinical Chorioamnionitis in Preterm Premature Rupture of Membranes</title><link>http://dx.doi.org/10.1111%2Fj.1600-0897.2011.01084.x</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Interleukin-6 as a Predictor of Subclinical Chorioamnionitis in Preterm Premature Rupture of Membranes</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Shilpa Gulati</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Sonu Bhatnagar</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Chitra Raghunandan</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Jayashree Bhattacharjee</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-03-01T00:00:00-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/j.1600-0897.2011.01084.x</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/j.1600-0897.2011.01084.x</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1111%2Fj.1600-0897.2011.01084.x</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">ORIGINAL ARTICLE</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">235</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">240</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p><b>Citation</b> Gulati S, Bhatnagar S, Raghunandan C, Bhattacharjee J. Interleukin-6 as a predictor of subclinical chorioamnionitis in preterm premature rupture of membranes. Am J Reprod Immunol 2012; 67: 235–240</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Problem </b> One of the major challenges faced by the clinicians in preterm premature rupture of the membranes (PPROM) is to correctly identify when a significant chorioamnionitis is evolving and decide timely delivery of the fetus. Measuring interleukin-6 levels in maternal serum can be useful for the identification of asymptomatic intrauterine infections in subjects with PPROM.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Method of study </b> A total of 75 pregnant women, of which 45 pregnant women presenting with PPROM between 24 and 34 weeks gestation and 30 healthy pregnant women without PPROM, were included in the study. Serum IL-6 levels were determined by solid-phase sandwich enzyme-linked immunosorbent assay (Diaclone Research, Besancon, France).</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Results </b> The mean serum IL-6 value at admission in the control group was 2.48 ± 2.7 pg/mL and in the study group was 11.86 ± 14.5 pg/mL (<em>P</em> = 0.001). Mean serum IL-6 concentrations at admission in subjects without histological chorioamnionitis were 3.98 ± 3.9 pg/mL and in those who had histological chorioamnionitis were 20.09 ± 16.8 pg/ml (<em>P</em> &lt; 0.001).</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Conclusion </b> Maternal serum IL-6 levels were significantly elevated in subjects with PPROM with infectious morbidity as compared to those without infectious morbidity in the present study. There was a significant rise in maternal serum IL-6 levels with increased duration of rupture of membranes and with evidence of histological chorioamnionitis and funisitis in the placenta.</p></div>]]></content:encoded><description>Citation Gulati S, Bhatnagar S, Raghunandan C, Bhattacharjee J. Interleukin-6 as a predictor of subclinical chorioamnionitis in preterm premature rupture of membranes. Am J Reprod Immunol 2012; 67: 235–240Problem  One of the major challenges faced by the clinicians in preterm premature rupture of the membranes (PPROM) is to correctly identify when a significant chorioamnionitis is evolving and decide timely delivery of the fetus. Measuring interleukin-6 levels in maternal serum can be useful for the identification of asymptomatic intrauterine infections in subjects with PPROM.Method of study  A total of 75 pregnant women, of which 45 pregnant women presenting with PPROM between 24 and 34 weeks gestation and 30 healthy pregnant women without PPROM, were included in the study. Serum IL-6 levels were determined by solid-phase sandwich enzyme-linked immunosorbent assay (Diaclone Research, Besancon, France).Results  The mean serum IL-6 value at admission in the control group was 2.48 ± 2.7 pg/mL and in the study group was 11.86 ± 14.5 pg/mL (P = 0.001). Mean serum IL-6 concentrations at admission in subjects without histological chorioamnionitis were 3.98 ± 3.9 pg/mL and in those who had histological chorioamnionitis were 20.09 ± 16.8 pg/ml (P &lt; 0.001).Conclusion  Maternal serum IL-6 levels were significantly elevated in subjects with PPROM with infectious morbidity as compared to those without infectious morbidity in the present study. There was a significant rise in maternal serum IL-6 levels with increased duration of rupture of membranes and with evidence of histological chorioamnionitis and funisitis in the placenta.</description></item><item rdf:about="http://dx.doi.org/10.1111%2Fj.1600-0897.2011.01090.x" xmlns="http://purl.org/rss/1.0/"><title>Profile of Inflammatory Mediators in Gestational Diabetes Mellitus: Phenotype and Genotype</title><link>http://dx.doi.org/10.1111%2Fj.1600-0897.2011.01090.x</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Profile of Inflammatory Mediators in Gestational Diabetes Mellitus: Phenotype and Genotype</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Bárbara Yasmin Gueuvoghlanian-Silva</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Maria Regina Torloni</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Rosiane Mattar</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Lilian Silveira de Oliveira</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Flávia Burim Scomparini</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Mary Uchiyama Nakamura</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Silvia Daher</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-03-01T00:00:00-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/j.1600-0897.2011.01090.x</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/j.1600-0897.2011.01090.x</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1111%2Fj.1600-0897.2011.01090.x</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">ORIGINAL ARTICLE</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">241</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">250</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p><b>Citation</b> Gueuvoghlanian-Silva BY, Torloni MR, Mattar R, de Oliveira LS, Scomparini FB, Nakamura MU, Daher S. Profile of inflammatory mediators in gestational diabetes mellitus: phenotype and genotype. Am J Reprod Immunol 2012; 67: 241–250</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Problem </b> Our study aimed to assess <em>in vitro</em> production of IL-10, IL-6, TNF-A, and adiponectin serum levels in pregnant women with and without gestational diabetes mellitus (GDM) and to investigate a possible association between GDM and <em>IL-10</em>−1082 A&gt;G (rs1800896), <em>IL-6</em>−174 G&gt;C (rs1800795), <em>TNF-A</em>−308 G&gt;A (rs1800629), <em>adiponectin</em> +45 T&gt;G (rs2241766), and <em>adiponectin</em>−11377 C&gt;G (rs266729) gene polymorphisms.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Method of study </b> This case–control study included 79 women with GDM and 169 healthy controls (C) grouped according to pre-pregnancy BMI. IL-10, IL-6, and TNF-A culture supernatant and adiponectin serum levels were assessed by ELISA. DNA genotype was performed by PCR-RFLP.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Results </b> Adiponectin levels were significantly higher in C than GDM women, even within the same BMI category. Cytokines levels were similar between the groups. There were no associations between GDM and the analyzed gene polymorphisms.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Conclusions </b> Women with GDM have significantly lower adiponectin levels in the third trimester, regardless of BMI.</p></div>]]></content:encoded><description>Citation Gueuvoghlanian-Silva BY, Torloni MR, Mattar R, de Oliveira LS, Scomparini FB, Nakamura MU, Daher S. Profile of inflammatory mediators in gestational diabetes mellitus: phenotype and genotype. Am J Reprod Immunol 2012; 67: 241–250Problem  Our study aimed to assess in vitro production of IL-10, IL-6, TNF-A, and adiponectin serum levels in pregnant women with and without gestational diabetes mellitus (GDM) and to investigate a possible association between GDM and IL-10−1082 A&gt;G (rs1800896), IL-6−174 G&gt;C (rs1800795), TNF-A−308 G&gt;A (rs1800629), adiponectin +45 T&gt;G (rs2241766), and adiponectin−11377 C&gt;G (rs266729) gene polymorphisms.Method of study  This case–control study included 79 women with GDM and 169 healthy controls (C) grouped according to pre-pregnancy BMI. IL-10, IL-6, and TNF-A culture supernatant and adiponectin serum levels were assessed by ELISA. DNA genotype was performed by PCR-RFLP.Results  Adiponectin levels were significantly higher in C than GDM women, even within the same BMI category. Cytokines levels were similar between the groups. There were no associations between GDM and the analyzed gene polymorphisms.Conclusions  Women with GDM have significantly lower adiponectin levels in the third trimester, regardless of BMI.</description></item><item rdf:about="http://dx.doi.org/10.1111%2Fj.1600-0897.2011.01092.x" xmlns="http://purl.org/rss/1.0/"><title>Hereditary Thrombophilia, Anti-Beta2 Glycoprotein 1 IgM, and Anti-Annexin V Antibodies in Recurrent Pregnancy Loss</title><link>http://dx.doi.org/10.1111%2Fj.1600-0897.2011.01092.x</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Hereditary Thrombophilia, Anti-Beta2 Glycoprotein 1 IgM, and Anti-Annexin V Antibodies in Recurrent Pregnancy Loss</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Suat Karata</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Yavuz Aydin</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Fahri Ocer</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Aysenur Buyru</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Huriye Balci</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-03-01T00:00:00-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/j.1600-0897.2011.01092.x</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/j.1600-0897.2011.01092.x</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1111%2Fj.1600-0897.2011.01092.x</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">ORIGINAL ARTICLE</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">251</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">255</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p><b>Citation</b> Karata S, Aydin Y, Ocer F, Buyru A, Balci H. Hereditary Thrombophilia, anti-beta2 glycoprotein 1 IgM, and anti-annexin V antibodies in recurrent pregnancy loss. Am J Reprod Immunol 2012; 67: 251–255</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Problem</b> We investigated the beta2-glycoprotein I and anti-annexin V antibodies as anti-phospholipid–cofactor antibodies; and factor V G1691A Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase (MTHFR) C677T mutations as hereditary thrombophilia in recurrent pregnancy losses (RPL).</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Method of study</b> Study group consisted of 84 women with recurrent pregnancy loss and control group consisted of 84 women having at least one live birth.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Results</b> Methylenetetrahydrofolate reductase C677T homozygous mutation was detected in 28.5% of the study group and in 14.2% of the controls, and the difference was highly significant (<em>P</em> &lt; 0.001). Heterozygous mutation of this gene was found in 64.3% of the study population and in 38.1% of the controls, and difference in heterozygous mutation frequency was also significant (<em>P</em> &lt; 0.001). Both homozygous and heterozygous mutations of PT G20210A and factor V G1691A were not different between the groups. There was no significant difference in anti-annexin V levels and anti-beta2-gp 1 levels of the groups.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Conclusion</b> We concluded that both homozygous and heterozygous mutations of MTHFR C677T were related with RPL in Caucasian women.</p></div>]]></content:encoded><description>Citation Karata S, Aydin Y, Ocer F, Buyru A, Balci H. Hereditary Thrombophilia, anti-beta2 glycoprotein 1 IgM, and anti-annexin V antibodies in recurrent pregnancy loss. Am J Reprod Immunol 2012; 67: 251–255Problem We investigated the beta2-glycoprotein I and anti-annexin V antibodies as anti-phospholipid–cofactor antibodies; and factor V G1691A Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase (MTHFR) C677T mutations as hereditary thrombophilia in recurrent pregnancy losses (RPL).Method of study Study group consisted of 84 women with recurrent pregnancy loss and control group consisted of 84 women having at least one live birth.Results Methylenetetrahydrofolate reductase C677T homozygous mutation was detected in 28.5% of the study group and in 14.2% of the controls, and the difference was highly significant (P &lt; 0.001). Heterozygous mutation of this gene was found in 64.3% of the study population and in 38.1% of the controls, and difference in heterozygous mutation frequency was also significant (P &lt; 0.001). Both homozygous and heterozygous mutations of PT G20210A and factor V G1691A were not different between the groups. There was no significant difference in anti-annexin V levels and anti-beta2-gp 1 levels of the groups.Conclusion We concluded that both homozygous and heterozygous mutations of MTHFR C677T were related with RPL in Caucasian women.</description></item><item rdf:about="http://dx.doi.org/10.1111%2Fj.1600-0897.2011.01068.x" xmlns="http://purl.org/rss/1.0/"><title>Distinct Subpopulations of Epithelial Ovarian Cancer Cells Can Differentially Induce Macrophages and T Regulatory Cells Toward a Pro-Tumor Phenotype</title><link>http://dx.doi.org/10.1111%2Fj.1600-0897.2011.01068.x</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Distinct Subpopulations of Epithelial Ovarian Cancer Cells Can Differentially Induce Macrophages and T Regulatory Cells Toward a Pro-Tumor Phenotype</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Ayesha B. Alvero</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Michele K. Montagna</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Vinicius Craveiro</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Lanzhen Liu</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Gil Mor</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-03-01T00:00:00-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/j.1600-0897.2011.01068.x</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/j.1600-0897.2011.01068.x</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1111%2Fj.1600-0897.2011.01068.x</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">ORIGINAL ARTICLE</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">256</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">265</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p><b>Citation</b> Alvero AB, Montagna MK, Craveiro V, Liu L, Mor G. Distinct subpopulations of epithelial ovarian cancer cells can differentially induce macrophages and T regulatory cells toward a pro-tumor phenotype. Am J Reprod Immunol 2012; 67: 256–265</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Problem </b> Presence of immune infiltrates in the tumor does not always correlate with an anti-tumoral immune response. We previously identified two subpopulations of epithelial ovarian cancer (EOC) cells with differential cytokine profile. We hypothesize that these two subpopulations of EOC cells may differentially regulate the immune phenotype in the tumor microenvironment and therefore affect the immune response.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Method of Study </b> Macrophages derived from CD14+ monocytes and naive CD4+T cells were treated with conditioned media from two subpopulations of EOC cells. Differentiation markers and phagocytic activity were measured by western blot analysis and flow cytometry. Cytokine levels were quantified using xMAP technology.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Results </b> Type I EOC cells are able to enhance macrophages’ capacity for tumor repair and renewal by enhancing expression of scavenger receptors and by promoting the secretion of cytokines associated with tissue repair. On the other hand, type II EOC cells are able to create a tolerant microenvironment and prevent an immune response by inducing macrophages’ to secrete IL-10 and by promoting the generation of T regs.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Conclusion </b> We demonstrate that each ovarian cancer cell subpopulation can induce a unique phenotype of macrophages and T cells, both associated with tumor-supportive function.</p></div>]]></content:encoded><description>Citation Alvero AB, Montagna MK, Craveiro V, Liu L, Mor G. Distinct subpopulations of epithelial ovarian cancer cells can differentially induce macrophages and T regulatory cells toward a pro-tumor phenotype. Am J Reprod Immunol 2012; 67: 256–265Problem  Presence of immune infiltrates in the tumor does not always correlate with an anti-tumoral immune response. We previously identified two subpopulations of epithelial ovarian cancer (EOC) cells with differential cytokine profile. We hypothesize that these two subpopulations of EOC cells may differentially regulate the immune phenotype in the tumor microenvironment and therefore affect the immune response.Method of Study  Macrophages derived from CD14+ monocytes and naive CD4+T cells were treated with conditioned media from two subpopulations of EOC cells. Differentiation markers and phagocytic activity were measured by western blot analysis and flow cytometry. Cytokine levels were quantified using xMAP technology.Results  Type I EOC cells are able to enhance macrophages’ capacity for tumor repair and renewal by enhancing expression of scavenger receptors and by promoting the secretion of cytokines associated with tissue repair. On the other hand, type II EOC cells are able to create a tolerant microenvironment and prevent an immune response by inducing macrophages’ to secrete IL-10 and by promoting the generation of T regs.Conclusion  We demonstrate that each ovarian cancer cell subpopulation can induce a unique phenotype of macrophages and T cells, both associated with tumor-supportive function.</description></item></rdf:RDF>
